Device and method for receiving fluid

The device addresses the complexity and pain associated with existing fluid extraction methods by using a movable interface and vacuum source to uniformly distribute force, enabling efficient and reliable fluid sampling without specialized training.

JP2024164161AInactive Publication Date: 2024-11-26YOURBIO HEALTH INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024141873
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-01-10
Filing Date
2024-08-23
Publication Date
2024-11-26
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing methods for obtaining blood or other fluids from the skin, such as phlebotomy and fingerstick sampling, are complex, require specialized training, and often cannot be performed in non-medical settings, and fingerstick sampling is painful and unreliable for obtaining sufficient fluid volumes.

Method used

A device for fluid reception from a subject, comprising a device actuator, needles or flow activators, a vacuum source, and an interface with movable sidewalls, designed to facilitate fluid extraction by applying reduced pressure and ensuring uniform force distribution on the skin.

Benefits of technology

The device allows for efficient, pain-free, and reliable extraction of fluid samples without specialized training, suitable for use in various settings, including non-medical environments.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024164161000001_ABST
    Figure 2024164161000001_ABST
Patent Text Reader

Abstract

To provide an excellent device and method for receiving fluid.SOLUTION: The present disclosure generally relates to receiving bodily fluid through a device opening. In one aspect, the device includes an interface that facilitates piercing of skin and / or withdrawal of fluid from the skin. The skin may be subjected to vacuum from a vacuum source. In one aspect of the present disclosure, a device for receiving fluid from an object is provided. The device includes: a device actuator; one or more needles or fluid activators configured to discharge the fluid from the object; a vacuum source; a support body having a side wall; and an interface which is configured to contact a subject skin and defines an opening through which the fluid is received from the subject. At least a part of the interface is moveable relative to the sidewall of the support in some cases.SELECTED DRAWING: Figure 3B
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] (CROSS REFERENCE TO RELATED APPLICATIONS) This application claims the benefit of U.S. Provisional Patent Application No. 62 / 842,303, filed May 2, 2019, U.S. Provisional Patent Application No. 62 / 880,137, filed July 30, 2019, U.S. Provisional Patent Application No. 62 / 942,540, filed December 2, 2019, U.S. Provisional Patent Application No. 62 / 948,788, filed December 16, 2019, and U.S. Provisional Patent Application No. 62 / 959,868, filed January 10, 2020, each of which is incorporated herein by reference.

[0002] The present disclosure relates generally to systems and methods for receiving fluids or other substances, such as blood or interstitial fluid, from a subject, for example, from the skin and / or beneath the skin. [Background technology]

[0003] Phlebotomy or venipuncture is the process of obtaining intravenous access or obtaining a sample of venous blood for the purpose of intravenous therapy. The process is typically performed by health care professionals, including paramedics, phlebotomists, physicians, nurses, and the like. For example, Vacutainers TM (Becton, Dickinson and company) and Vacuette TM Substantial equipment is required to obtain blood from a subject, including the use of reduced pressure (vacuum) tubing, such as the Greiner Bio-One GmBH system. Other equipment includes hypodermic needles, syringes, and the like. However, such procedures are complex, require sophisticated training of the practitioner, and often cannot be performed in non-medical settings. Thus, improvements in methods for obtaining blood or other fluids from or through the skin remain needed.

[0004] Sampling capillary blood by finger prick requires less training than venipuncture and can be self-administered. A disadvantage of finger prick sampling is that it is painful and it can be difficult to reliably obtain a blood sample of sufficient volume and quality for testing. The practice of pricking other sites, such as the arm, thigh, or palm, has been used to alleviate the pain associated with finger pricks, but the lower capillary density in these areas makes it difficult to obtain an adequate sample volume for testing. Summary of the Invention [Means for solving the problem]

[0005] In some embodiments, the present disclosure relates generally to devices and methods for receiving fluids, such as blood, from a subject. The subject matter of the present disclosure in some cases involves interrelated products, alternative solutions to a particular problem, and / or multiple different uses of one or more systems and / or articles.

[0006] In one aspect of the disclosure, a device for receiving fluid from a subject is provided that includes a device actuator, one or more needles or flow activators configured to expel fluid from the subject, a vacuum source, a support having a sidewall, and an interface configured to contact the skin of the subject, the interface defining an opening through which fluid is received from the subject. At least a portion of the interface is movable, in some cases, relative to the sidewall of the support.

[0007] In another aspect of the disclosure, a device for receiving a fluid from a subject is provided. The device includes a housing including an inlet sidewall defining an opening for receiving the fluid in the housing, a device actuator, one or more needles or flow activators configured to expel the fluid from the subject, and an interface configured to contact the skin of the subject. The interface in some cases includes a distal surface configured to contact the skin of the subject, the inlet sidewall includes a distal end, and the surface area of ​​the distal surface of the inlet sidewall is, in some embodiments, greater than the surface area of ​​the distal end of the inlet sidewall.

[0008] In another aspect of the disclosure, a device for receiving a fluid from a subject is provided. The device includes a device actuator, one or more needles or flow activators configured to expel fluid from the subject, a vacuum source, and an interface configured to contact the skin of the subject. The interface defines an opening through which the fluid is received from the subject. The interface has a sidewall that comprises a funnel shape.

[0009] In another aspect of the disclosure, a device for receiving a fluid from a subject is provided. The device includes a device actuator, one or more needles or flow activators configured to expel the fluid from the subject, a vacuum source with a flexible dome made from a first material, and a shell made from a second material having a higher Young's modulus than that of the first material. The device actuator is movable relative to the shell. Movement of the device actuator relative to the shell causes compression of the flexible dome.

[0010] In another aspect of the present disclosure, a device for receiving fluid from a subject is provided. In one set of embodiments, the device comprises one or more flow activators configured to cause fluid to be expelled from the subject upon insertion into the skin of the subject, a vacuum source capable of applying reduced pressure to the skin to withdraw the expelled fluid from the subject, and an interface configured to contact the skin of the subject, the interface defining an opening through which fluid is received from the subject into the device, the interface first contacting the skin at a first contact area, and after the reduced pressure is applied to the skin, the interface contacting the skin at a second contact area. In some cases, the second contact area surrounds the first contact area. In some embodiments, when the vacuum is applied, the skin is drawn into the interface area, thereby causing the interface to contact the skin at the second contact area.

[0011] In another aspect of the present disclosure, a device for receiving fluid from a subject is provided. In one set of embodiments, the device comprises one or more flow activators configured to cause fluid to be expelled from the subject upon insertion into the skin of the subject, a vacuum source capable of applying reduced pressure to the skin to withdraw the expelled fluid from the subject, and an interface configured to contact the skin of the subject at a contact area, the interface defining an opening through which fluid is received from the subject into the device, and the interface configured to spread the force substantially uniformly at the contact area. In some cases, the force applied to the skin through the interface at any location varies by + / - 20% or less from the average force applied to the skin.

[0012] In another aspect of the present disclosure, a device for receiving fluid from a subject is provided. In one set of embodiments, the device comprises one or more flow activators configured to cause fluid to be released from the subject upon insertion into the skin of the subject, a vacuum source capable of applying reduced pressure to the skin to withdraw the released fluid from the subject, and an interface configured to contact the skin of the subject, the interface defining an opening through which fluid is received from the subject into the device, the interface having a Young's modulus of less than 1 GPa. In some cases, the Young's modulus may be less than 30 GPa, less than 20 GPa, less than 10 GPa, less than 5 GPa, less than 3 GPa, less than 2 GPa, less than 1 GPa, less than 500 MPa, less than 300 MPa, less than 200 MPa, less than 100 MPa, less than 50 MPa, less than 30 MPa, less than 20 MPa, less than 10 MPa, less than 5 MPa, etc.

[0013] In another aspect of the present disclosure, a device for receiving fluid from a subject is provided. In one set of embodiments, the device comprises one or more flow activators configured to cause fluid to be expelled from the subject upon insertion into the skin of the subject, a vacuum source capable of applying reduced pressure to the skin to withdraw the expelled fluid from the subject, and an interface configured to contact the skin of the subject, the interface defining an opening through which fluid is received from the subject into the device, the interface defining a surface that slopes inwardly toward the opening. In some cases, the slope is greater than at least 3°, at least 5°, at least 7°, or at least 10° at least at one location within the interface.

[0014] In another aspect, the present disclosure includes a method of making one or more of the embodiments described herein, such as a device for receiving a fluid. In yet another aspect, the present disclosure includes a method of using one or more of the embodiments described herein, such as a device for receiving a fluid.

[0015] Other advantages and novel features of the present disclosure will become apparent from the following detailed description of various non-limiting embodiments of the present disclosure, when considered in conjunction with the accompanying figures. In the event that the present specification and a document incorporated by reference include conflicting and / or inconsistent disclosure, the present specification shall control. In the event that two or more documents incorporated by reference include conflicting and / or inconsistent disclosure with respect to each other, the document having the later effective date shall control. The present invention provides, for example, the following: (Item 1) 1. A device for receiving a fluid from a subject, comprising: A device actuator; one or more flow activators configured to cause fluid to be expelled from the object; A vacuum source; A support having a sidewall; an interface configured to contact a skin of the subject, the interface defining an opening through which fluid is received from the subject; Equipped with At least a portion of the interface is movable relative to a sidewall of the support. (Item 2) 2. The device of claim 1, wherein the interface is made from a first material and the sidewall of the support is made from a second material, the first material having a lower Young's modulus than the Young's modulus of the second material. (Item 3) 3. The device of claim 1 or 2, wherein the interface comprises a main body and a first section, the first section connected to the main body by a region having a reduced cross-sectional area compared to the main body, the region allowing the first section to move relative to the main body, the first section being movable relative to a sidewall of the support. (Item 4) 4. The device of any one of items 1-3, wherein the diameter of the opening is smaller than the largest diameter of the side wall of the support. (Item 5) 5. The device of any one of claims 1-4, wherein the sidewall forms a cylindrical shape. (Item 6) 6. The device of any one of claims 1-5, wherein the sidewall forms a funnel shape. (Item 7) 7. The device of any one of claims 1-6, wherein the interface comprises a distal surface configured to contact the skin of the subject, the sidewall comprises a distal end, and a surface area of ​​the distal surface of the interface is greater than a surface area of ​​the distal end of the sidewall. (Item 8) 8. The device of any one of claims 1-7, wherein the interface is attached to the side wall. (Item 9) 9. The device of any one of claims 1-8, wherein the interface is made of silicone. (Item 10) 10. The device of any one of claims 1-9, wherein the interface is made from a thermoplastic elastomer. (Item 11) 11. The device of any one of claims 1-10, wherein the interface has a horizontal portion and a vertical portion, the horizontal portion being movable relative to the support. (Item 12) 12. The device of any one of claims 1-11, wherein the interface has a horizontal portion and a C-shaped portion that transitions the interface from the support to the horizontal portion of the interface. (Item 13) Item 13. The device of any one of items 1-12, wherein the interface has a horizontal shape with rounded corners at the opening. (Item 14) Item 14. The device of any one of items 1-13, wherein the interface comprises an L-shape having a vertical portion and a horizontal portion. (Item 15) Item 15. The device of item 14, wherein a neck portion joins the vertical portion to the horizontal portion, the neck portion having a width less than a width of the vertical portion and a width of the horizontal portion. (Item 16) 16. The device of any one of claims 1-15, wherein the vacuum source comprises a vacuum valve that generates a vacuum when the valve expands from a smaller volume to a larger volume. (Item 17) 17. The device of any one of items 1-16, further comprising a storage chamber configured to store a fluid received in the device. (Item 18) Item 18. The device of item 17, wherein the storage chamber is removable from the device. (Item 19) Item 19. The device of any one of items 1-18, wherein the flow activator comprises a needle. (Item 20) 20. The device of any one of claims 1-19, wherein the flow activator comprises a blade. (Item 21) 1. A device for receiving a fluid from a subject, comprising: a housing including an inlet sidewall defining an opening for receiving a fluid within the housing; A device actuator; one or more flow activators configured to cause fluid to be expelled from the object; an interface configured to contact a skin of the subject; Equipped with A device, wherein the interface includes a distal surface configured to contact the skin of the subject, the entrance sidewall includes a distal end, and a surface area of ​​the distal surface of the entrance sidewall is greater than a surface area of ​​the distal end of the entrance sidewall. (Item 22) Item 22. The device of item 21, wherein a portion of the interface extends radially inward from the inlet sidewall. (Item 23) Item 23. The device of item 22, wherein the interface includes a hole through which fluid is received, the diameter of the hole in the interface being smaller than the diameter of the opening in the inlet sidewall. (Item 24) 24. The device of any one of claims 21-23, wherein the flow activator comprises a needle. (Item 25) 25. The device of any one of claims 21-24, wherein the flow activator comprises a blade. (Item 26) 1. A device for receiving a fluid from a subject, comprising: A device actuator; one or more flow activators configured to cause fluid to be expelled from the object; A vacuum source; an interface configured to contact a skin of the subject, the interface defining an opening through which fluid is received from the subject, the interface having a sidewall with a funnel shape; A device comprising: (Item 27) 27. The device of claim 26, further comprising a lubricant on at least a portion of the inlet sidewall. (Item 28) 28. The device of claim 27, wherein the lubricant consists of yellow petrolatum. (Item 29) 29. The device of any one of claims 26-28, wherein the flow activator comprises a needle. (Item 30) 30. The device of any one of claims 26-29, wherein the flow activator comprises a blade. (Item 31) 1. A device for receiving a fluid from a subject, comprising: A device actuator; one or more flow activators configured to cause fluid to be expelled from the object; a vacuum source comprising a flexible dome made from a first material; a shell made of a second material having a higher Young's modulus than that of the first material, the device actuator being movable relative to the shell; and Equipped with A device, wherein movement of the device actuator relative to the shell causes compression of the flexible dome. (Item 32) Item 32. The device of item 31, wherein the shell includes an opening through which at least a portion of the device actuator extends. (Item 33) Item 33. The device of item 32, wherein the device actuator includes a user contact portion and a stem, the stem extending through an opening in the shell. (Item 34) 34. The device of any one of claims 31-33, wherein the flexible dome has a first shape prior to compression and a second shape during compression, the flexible dome being biased to return to its first shape when the flexible dome is no longer under compression. (Item 35) Item 35. The device of item 34, wherein the return of the flexible dome from the second shape to the first shape creates a vacuum. (Item 36) a one-way vent that allows air movement therethrough during compression of the flexible dome from the first shape to the second shape but prevents air movement therethrough during return of the flexible dome from the second shape to the first shape. Item 36. The device of item 35, further comprising: (Item 37) 37. The device of any one of claims 31-36, wherein the flexible dome includes a wall having a recessed circumferential shoulder. (Item 38) 38. The device of any one of claims 31-37, further comprising a ratchet mechanism that resists movement of the device actuator relative to the shell in a direction away from the flexible dome. (Item 39) Item 39. The device of item 38, wherein the ratchet mechanism comprises a ratchet and a pawl. (Item 40) 40. The device of claim 39, wherein the pawl is attached to the shell and the ratchet is attached to the device actuator. (Item 41) Item 41. The device of item 40, wherein the device actuator includes a user contact portion and a stem, the ratchet being located on the stem. (Item 42) 42. The device of claim 40 or 41, wherein the shell includes an opening through which at least a portion of the device actuator extends, and the claw is located within the opening. (Item 43) 43. The device of claim 39-42, wherein the ratchet includes a plurality of teeth and a first tooth, the user contact portion being further away from the first tooth than the plurality of teeth, and the first tooth being reversed in direction relative to the plurality of teeth. (Item 44) The device of any one of the preceding items, further comprising a retraction actuator and a puncture assembly, the puncture assembly including a deployment actuator and the one or more flow activators, the puncture assembly being movable in a deployment direction toward the opening, and the retraction actuator being compressed during movement of the puncture assembly toward the opening. (Item 45) Item 45. The device of item 44, wherein the deployment actuator stores potential energy during movement of the puncture assembly toward the opening. (Item 46) 46. ​​The device of claim 44 or 45, wherein the deployment actuator releases stored potential energy in response to contact of the puncture assembly with the user's skin, causing the one or more flow activators to move toward and puncture the user's skin. (Item 47) 47. The device of claim 44-46, wherein the retraction actuator comprises a spring having one or more cantilevered spiral arms. (Item 48) 48. The device of claim 44, wherein the puncture assembly further includes a guide housing, the one or more flow activators are movable through at least a portion of the guide housing during deployment, and the guide housing contacts the retraction spring. (Item 49) Item 49. The device of item 48, wherein the retraction spring slides relative to the guide housing during compression of the retraction spring. (Item 50) 50. The device of claim 44, 47, or 49, wherein the retraction actuator is attached to the support. (Item 51) Item 49. The device of item 48, wherein the guide housing includes a notch that contacts the retraction spring. (Item 52) 52. The device of claim 48, wherein the puncture assembly further includes a latch engaged with a support on the guide housing, the latch being movable through at least a portion of the guide housing when the latch is released. (Item 53) Item 53. The device of item 52, further comprising a latch release, wherein movement of the latch release beyond a threshold travel distance disengages the latch from the support. (Item 54) 54. The device of claim 52 or 53, further comprising a latch release, wherein an actuation force applied to the latch release that exceeds a threshold force disengages the latch from the support independent of a travel distance of the latch release. (Item 55) 55. The device of claim 52-54, wherein the guide housing includes a latch track that guides linear movement of the latch through the guide housing. (Item 56) 56. The device of claim 48, wherein the support includes a guide housing track that guides linear movement of the guide housing relative to the support. (Item 57) 57. The device of claim 44-56, wherein the deployment actuator comprises a deployment spring and the retraction actuator comprises a retraction spring, the spring constant of the deployment spring being stiffer than the spring constant of the retraction spring. (Item 58) 58. The device of claim 44-57, wherein the deployment actuator comprises a deployment spring and the retraction actuator comprises a retraction spring, the deployment spring and the retraction spring being arranged in series. (Item 59) 49. The device of claim 44-48, wherein the deployment actuator comprises a deployment spring and the retraction actuator comprises a retraction spring, the deployment spring and the retraction spring being arranged in parallel. (Item 60) The device of items 52-59, wherein the puncture assembly further includes a push cap including a contact surface configured to contact the latch and release the latch, the deployment spring being compressed between the push cap and the latch as the push cap moves toward the latch, and actuation of the device moves the push cap in a deployment direction toward the opening. (Item 61) Item 61. The device of item 60, wherein the guide housing includes a push cap track that guides linear movement of the push cap through the guide housing. (Item 62) 62. The device according to claim 60 or 61, wherein the deployment spring is attached to the pushing cap. (Item 63) 63. The device of claim 52-62, wherein the deployment actuator comprises a deployment spring, and the latch and the deployment spring are integrally formed as a single component. (Item 64) 64. The device of any one of claims 52-63, further comprising a latch release, the deployment actuator comprising a deployment spring, the latch release and the deployment spring being integrally formed as a single component. (Item 65) 64. The device of any one of claims 52-63, further comprising a latch release, the deployment actuator comprising a deployment spring, the latch, latch release, and the deployment spring being integrally formed as a single component. (Item 66) 66. The device of claim 44-65, wherein the deployment actuator comprises a spring having a contoured, non-coiled shape. (Item 67) 53. The device of any one of claims 48-52, wherein the guide housing includes a spring track that receives at least a portion of the spring and guides linear movement of the spring through the guide housing. (Item 68) 68. The device of claim 52-67, wherein the latch has a latch width that extends from a first arm of the latch to a second arm of the latch, and the deployment actuator comprises a spring having an undulating non-coiled shape, the spring having a spring width that extends from a first curve of the spring to a second curve of the spring, the first and second curves point in opposite directions, and the spring width is oriented perpendicular to the latch width. (Item 69) The device of any one of the preceding claims, further comprising a puncture assembly including a deployment actuator and the one or more flow activators, and further comprising a positive stop limiting the travel distance of the one or more flow activators. (Item 70) 70. The device of claim 69, wherein the positive stop comprises a peg that abuts against a contact surface. (Item 71) 71. The device of claim 70, further comprising a guide housing, wherein the one or more flow activators are movable through at least a portion of the guide housing during deployment, the peg is coupled to the deployment actuator, and the contact surface is coupled to the guide housing. (Item 72) Item 37. The device of item 36, wherein the one-way vent comprises an umbrella valve. (Item 73) 37. The device of any one of items 31-36, wherein the flexible dome is more difficult to compress during an initial phase of compression than during a final phase of compression. (Item 74) A device, comprising: a flexible dome having a first shape prior to compression and a second shape during compression, said flexible dome being biased to return toward said first shape when said flexible dome is no longer under compression; a one-way vent through which air exits the flexible dome when the flexible dome is compressed; and Equipped with A device, wherein the flexible dome is more difficult to compress during an initial phase of compression than during a later phase of compression. (Item 75) Item 75. The device of item 74, wherein the return of the flexible dome from the second shape toward the first shape creates a vacuum. (Item 76) 76. The device of any one of items 74 or 75, wherein the flexible dome includes a wall having a recessed circumferential shoulder. [Brief description of the drawings]

[0016] Non-limiting embodiments incorporating one or more aspects of the present disclosure will now be described, by way of example, with reference to the accompanying drawings, which are schematic and are not necessarily intended to be drawn to scale. In the drawings, each identical or nearly identical component shown is typically represented by a single numeral. For purposes of clarity, not every component will be labeled in every drawing, or every component of each embodiment of the present disclosure will be shown, unless illustration is necessary to enable those skilled in the art to understand the disclosure.

[0017] [Figure 1A] FIG. 1A is a side view of a support and interface of a fluid-receiving device according to an aspect of the present disclosure. [Figure 1B] FIG. 1B is a cross-sectional view of the support and interface of FIG. 1A. [Diagram 2] FIG. 2 is a cross-sectional view of the support and interface of FIG. 1A that are integrated with a fluid-accepting module to form a fluid-accepting device. [Figure 3A]FIG. 3A is the support and interface of FIG. 1A at atmospheric conditions. [Figure 3B] FIG. 3B is the support and interface of FIG. 1B under vacuum conditions. [Figure 4A] FIG. 4A is a side view of one embodiment of a support and interface of a fluid-accepting device. [Figure 4B] FIG. 4B is a cross-sectional view of the support and interface of FIG. 4A. [Figure 5A] FIG. 5A is a bottom perspective view of the support and interface of FIG. 4A. [Figure 5B] FIG. 5B is a partial cutaway perspective view of the support and interface of FIG. 4A. [Figure 6] FIG. 6 is a perspective view of the support and interface of FIG. 4A that are integrated with a fluid-accepting module to form a fluid-accepting device. [Figure 7] 7 is a side view of the fluid receiving device of FIG. [Figure 8] 8 is a bottom view of the fluid receiving device of FIG. 6. FIG. [Figure 9] 9 is a cross-sectional view of the fluid receiving device of FIG. 6 taken along line 9-9 of FIG. [Figure 10A] FIG. 10A is a side view of one embodiment of a support and interface of a fluid-receiving device. [Figure 10B] FIG. 10B is a cross-sectional view of the support and interface of FIG. 10A. [Figure 11A] FIG. 11A is a side view of one embodiment of a support and interface of a fluid-receiving device. [Figure 11B] FIG. 11B is a cross-sectional view of the support and interface of FIG. 11A. [Figure 12] FIG. 12 is a cross-sectional view of one embodiment of a support and interface of a fluid-accepting device. [Figure 13A] FIG. 13A is a side view of one embodiment of a support and interface of a fluid-receiving device. [Figure 13B] FIG. 13B is a cross-sectional view of the support and interface of FIG. 13A. [Figure 14A]FIG. 14A is a side view of one embodiment of a support and interface of a fluid-receiving device. [Figure 14B] FIG. 14B is a cross-sectional view of the support and interface of FIG. 14A. [Figure 15A] FIG. 15A is a side view of one embodiment of a fluid receiving device having the interface of the embodiment of FIG. 14A. [Figure 15B] FIG. 15B is a cross-sectional view of the fluid receiving device of FIG. 15A. [Figure 16A] FIG. 16A is a side view of one embodiment of a fluid receiving device having an interface. [Figure 16B] FIG. 16B is a cross-sectional view of the fluid receiving device of FIG. 16A. [Figure 17A] FIG. 17A is a perspective view of one embodiment of a support and interface that is integrated with a fluid-accepting module to form a fluid-accepting device. [Figure 17B] FIG. 17B is a side view of the fluid receiving device of FIG. 17A. [Figure 17C] FIG. 17C is a front view of the fluid receiving device of FIG. 17A. [Figure 17D] FIG. 17D is a cross-sectional view of the fluid-receiving device of FIG. 17A taken along line 17D-17D of FIG. 17C. [Figure 17E] FIG. 17E is a partial cutaway view of the fluid receiving device of FIG. 17A taken along line 17E-17E of FIG. 17C. [Figure 18] FIG. 18 is a perspective view of one embodiment of a fluid receiving device having a device actuator and a shell from one side. [Figure 19] FIG. 19 is a front perspective partial cutaway view of the fluid receiving device of FIG. 18 with a portion of the shell hidden from view. [Figure 20] 20 is a rear perspective partial cutaway view of the fluid receiving device of FIG. 18 with a portion of the shell hidden from view. [Figure 21] FIG. 21 is the fluid-accepting device of FIG. 18 with the device actuator in a deployed position and the flexible dome in a compressed configuration. [Figure 22] 22 is a rear perspective partial cutaway view of the fluid-receiving device of FIG. 21, with the device actuator in a deployed position and the flexible dome in a compressed configuration. [Figure 23] 23 is a perspective, partial cutaway view of the fluid-receiving device of FIG. 18, with the piercing assembly, a portion of the shell, and a portion of the flexible dome hidden from view. [Figure 24] 24 is a perspective partial cutaway view of the fluid-receiving device of FIG. 23, with the device actuator in a deployed position and the flexible dome in a compressed configuration. [Diagram 25] FIG. 25 is a cross-sectional view of the fluid-accepting device of FIG. 18 showing the interaction between the device actuator, the shell, and the flexible dome. [Figure 26] FIG. 26 is a perspective view of a shell of a fluid receiving device. [Figure 27] FIG. 27 is a top view of the shell of FIG. [Figure 28] FIG. 28 is a perspective view of the device actuator. [Figure 29] FIG. 29 is a bottom view of the device actuator of FIG. [Diagram 30] FIG. 30 is a partial cutaway view of a fluid receiving device showing the interaction between the device actuator and the shell. [Diagram 31] FIG. 31 is a perspective view of another embodiment of a device actuator having a ratchet. [Diagram 32] 32 is a bottom view of the device actuator of FIG. 31. FIG. [Diagram 33] 33 is a side view of the device actuator of FIG. 31. FIG. [Figure 34-1] 34A-34G depict the sequence of interaction between a ratchet on the device actuator and a pawl on the shell. [Figure 34-2] 34A-34G depict the sequence of interaction between a ratchet on the device actuator and a pawl on the shell. [Diagram 35] FIG. 35 is a perspective view of a puncture assembly according to one embodiment. [Diagram 36] 36 is an exploded view of the puncture assembly of FIG. [Figure 37] 37 is a top view of the puncture assembly of FIG. 35. FIG. [Figure 38] 38 is a cross-sectional view of the puncture assembly of FIG. 35 taken along line 38-38 of FIG. [Figure 39] 39 is a top view of the puncture assembly of FIG. 35. FIG. [Diagram 40] FIG. 40 depicts a cross-sectional view of the puncture assembly of FIG. 35 taken along line 40-40 of FIG. 39 and a detailed view of the cutout in the guide housing of the puncture assembly. [Diagram 41] FIG. 41 is a perspective view of the puncture assembly of FIG. 35 and a detailed view of the cutout of the guide housing. [Diagram 42] 42 is a perspective view of a guide housing of the puncture assembly of FIG. 35. FIG. [Diagram 43] FIG. 43 is a front view of the guide housing of FIG. [Diagram 44] FIG. 44 is a top view of the guide housing of FIG. [Diagram 45] 45 is a perspective view of a support ring of the puncture assembly of FIG. 35. FIG. [Diagram 46] 46 is another perspective view of the support ring of FIG. 45. FIG. [Figure 47] FIG. 47 is a top view of the support ring of FIG. [Figure 48] FIG. 48 is a perspective view of a vacuum source in the form of a flexible dome. [Figure 49] 49 is a side view of the flexible dome of FIG. [Figure 50] 50 is a cross-sectional view of the flexible dome of FIG. 48 taken along line 50-50 of FIG. [Figure 51] FIG. 51 is a cross-sectional view of an alternative shape for a flexible dome. [Figure 52] FIG. 52 is a cross-sectional view of an alternative shape for a flexible dome. [Diagram 53] FIG. 53 is a schematic diagram of a distance based latch release. [Figure 54] FIG. 54 is a schematic diagram of a force based latch release. [Figure 55] FIG. 55 is a schematic diagram of a deployment actuator and a retraction actuator arranged as a spring in series. [Figure 56] FIG. 56 is a schematic diagram of a deployment actuator and a retraction actuator arranged as a spring in parallel. [Figure 57] FIG. 57 is a perspective view of one embodiment of a fluid-receiving device having a device actuator from one side. [Figure 58] FIG. 58 is a partial cutaway view of the fluid-receiving device of FIG. 57 with a portion of the housing hidden from view. [Figure 59] 59 is a rear perspective view of another partial cutaway view of the fluid receiving device of FIG. 57. FIG. [Figure 60] FIG. 60 is an exploded view of the fluid-receiving device of FIG. 57, according to one embodiment. [Figure 61] FIG. 61 is an exploded view of a puncture assembly including a spring and latch assembly, a needle, and a guide housing according to one embodiment. [Figure 62] FIG. 62 shows the puncture assembly of FIG. 61 in an assembled state. [Figure 63] 63 is a partial cutaway view of the piercing assembly of FIG. 62. FIG. [Figure 64] 64 is another partial cutaway view of the piercing assembly of FIG. [Figure 65] 65 is a cross-sectional view of the spring and latch assembly of the piercing assembly of FIG. 61. FIG. [Figure 66] 66 is a top view of the guide housing of FIG. [Figure 67] FIG. 67 is a front view of the guide housing of FIG. [Figure 68] 68 is a partial cutaway view of the guide housing of FIG. [Figure 69]69 is a perspective view of a housing of the fluid receiving device of FIG. 57. FIG. [Figure 70] FIG. 70 is a top view of the housing of FIG. [Figure 71] FIG. 71 is an exploded view of an alternative embodiment of the puncture assembly. [Figure 72] 72 is a further exploded view of the puncture assembly of FIG. [Figure 73] FIG. 73 shows the puncture assembly of FIG. 71 in an assembled state. [Figure 74] 74 is a partial cutaway view of the piercing assembly of FIG. [Figure 75] 75 is another partial cutaway view of the piercing assembly of FIG. [Figure 76] 76 is a top view of the guide housing of FIG. [Figure 77] 77 is a partial cutaway view of the guide housing of FIG. [Figure 78-1] 78A-78L are illustrative embodiments of cross sections of different support shapes. [Figure 78-2] 78A-78L are illustrative embodiments of cross sections of different support shapes. [Figure 79-1] 79A-79F are illustrative embodiments of different interface arrangements. [Figure 79-2] 79A-79F are illustrative embodiments of different interface arrangements. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0018] Aspects of the present disclosure are not limited in application to the details of construction and arrangement of components set forth in the following description or illustrated in the drawings. For example, although an illustrative embodiment relating to piercing the skin and receiving blood released from the pierced skin is discussed below, aspects of the present disclosure are not limited to use with devices that pierce the skin and / or receive blood. Other embodiments, such as devices that receive other bodily fluids without piercing, may be employed, and aspects of the present disclosure may be practiced or performed in various ways. Additionally, the phraseology and terminology used herein is for the purpose of description and should not be considered limiting.

[0019] It should be understood that in some fluid receiving devices, when obtaining fluid from the punctured skin via vacuum, the device is pressed down onto the skin, which exerts a force on the skin. It should be recognized that the force exerted on the skin can affect the quality and amount of fluid that is withdrawn from the skin. For example, in the case of blood, it should be recognized that if the device pinches, compresses, and / or stretches the skin too much, fluid may be prevented from being withdrawn from the skin due to, for example, blood vessels deforming and collapsing in response to the force exerted on the skin.

[0020] According to one aspect, in some embodiments, the device has an interface that helps distribute the force to the skin to avoid high concentrations of force on the skin. For example, in some cases, the interface may be configured to spread the force substantially evenly over the contact area. For example, the force applied to the skin through the interface at any location on the skin may vary by + / -50% or less, + / -40% or less, + / -30% or less, + / -20% or less, + / -10% or less, + / -5% or less, + / -3% or less, + / -2% or less, or + / -2% or less from the average force applied to the skin.

[0021] It should also be appreciated that in some embodiments, the penetration and withdrawal of fluid from skin that has bulged into a shape in response to the application of a vacuum may result in an increase in fluid volume and / or quality. Improved quality may include factors such as avoidance of red blood cell damage and release of cellular contents such as hemoglobin or potassium or reduced activation of coagulation. In some cases, the bulging of the skin may aid in the penetration of the needle into the skin at the full insertion depth of the needle. The bulging of the skin may keep the skin taut and it may be easier for the needle to penetrate into taut skin.

[0022] It should also be appreciated that in some cases, the bulging of the skin may induce vasodilation and increase blood flow. For example, the bulging of the skin may result in deformation of the bulging tissue, which mechanically dilates the blood vessels present within the tissue. This vasodilation may be amplified by the body's physiological response to the forces applied to the skin.

[0023] According to one aspect, in some embodiments, the device has an interface that allows for skin movement beneath the device, allows for mobilization of the skin into the device opening, encourages desirable skin bulging, and facilitates puncturing of the skin and subsequent withdrawal of fluid from the skin. In some cases, skin movement may occur after puncturing the skin, for example, movement may occur due to a vacuum generated after the skin is punctured.

[0024] According to another aspect, in some embodiments, the device interface helps maintain a seal with the skin during swelling and / or other movements of the skin.

[0025] The embodiments described herein relate to a fluid-receiving device having an interface for facilitating fluid withdrawal from a subject. In some embodiments, the interface may be integrated with a fluid-receiving module, which may serve to facilitate the withdrawal of fluid from a subject. The fluid-receiving module may include one or more of the following components: a vacuum source, a fluid storage chamber, and a flow activator. In some embodiments, the fluid-receiving device is arranged to pierce the skin of the subject, expose the pierced skin to a vacuum to draw fluid out of the skin, and collect the fluid inside the device. The device may be arranged to deploy multiple microneedles into the skin. The device may be positioned on any suitable location on the subject, such as on an arm or leg, on the back, on the abdomen, etc.

[0026] The subject is usually a human, although non-human subjects, e.g., other mammals such as dogs, cats, horses, rabbits, cows, pigs, sheep, goats, rats (e.g., Rattus norvegicus), mice (e.g., Mus musculus), guinea pigs, hamsters, primates (e.g., monkeys, chimpanzees, baboons, apes, gorillas, etc.), or the like, may be used in some cases.

[0027] The device may be activated by the subject and / or by another person (e.g., a health care provider such as a physician), or the device itself may be self-activated, for example in response to application to the subject's skin.

[0028] In one set of embodiments, the vacuum source is a pressure regulator that creates a pressure differential (such as a vacuum). The pressure regulator may be a pressure controller component or system that is capable of creating a pressure differential between two or more locations. The pressure differential should be sufficient to at least force the movement of fluids or other substances according to various embodiments as discussed herein, and the absolute pressures at the two or more locations are not important as long as their difference is adequate and their absolute values ​​are reasonable for the purposes discussed herein. For example, the pressure regulator may generate a pressure higher than atmospheric pressure at one location versus a lower pressure (atmospheric pressure or some other pressure) at another location, and the difference between the pressures is sufficient to cause fluid transport. In another example, the regulator or controller involves a pressure lower than atmospheric pressure (vacuum) at one location and a higher pressure (atmospheric pressure or a different pressure) at another location, and the difference between the pressures is sufficient to transport the fluid. Whenever "vacuum" or "pressure" is used herein in connection with a pressure regulator or pressure differential, as would be understood by one of ordinary skill in the art, it is understood that the opposite may be implemented as well, e.g., a vacuum chamber may be replaced in many instances with a pressure chamber to create a suitable pressure differential to cause the transport of fluids or other substances.

[0029] In some embodiments, the vacuum source is a component that a user can activate to generate a vacuum. The vacuum source activated to generate a vacuum may be purely mechanical or may require electricity to operate (e.g., battery operated or wired to receive electricity from a wall socket). In some embodiments, the vacuum source has a movable component, such as a flexible membrane, piston, expandable foam, or shape memory material, that is moved to generate a vacuum. In some illustrative embodiments, described in more detail below, the vacuum source may be a flexible dome that is compressible and may be biased to return to an expanded state, generating a vacuum during the return of the dome from the compressed state to the expanded state.

[0030] In some embodiments, the vacuum source may be actuated only once to generate a sufficient vacuum, while in other embodiments, the vacuum source may be actuated (e.g., pumped repeatedly) to generate the desired vacuum.

[0031] In some embodiments, the vacuum source is a prepackaged vacuum, i.e., a volume or chamber that is pre-evacuated at the time of manufacture to a pressure that is less than ambient pressure. In some embodiments, the user may actuate the fluid receiving device to open fluid communication to the prepackaged vacuum chamber. In some cases, the prepackaged vacuum is present in the device before the device is applied to the skin of the subject from which blood is to be drawn. Thus, the prepackaged vacuum is already present in the device when the device is first applied to the skin, in contrast to devices in which the device must first be applied to the skin before a vacuum can be created in the device. However, in other embodiments, the device does not need to have a prepackaged vacuum.

[0032] Thus, the device, in some embodiments, contains a "pre-packaged" vacuum chamber such that it is received "ready for use" without requiring any actuation to create a vacuum within the vacuum chamber. In some embodiments, the vacuum source is a Vacutainer TM tube, vacuette TM tube, or other commercially available vacuum tubes.

[0033] In some embodiments, device operation is entirely mechanical and does not require a power source (e.g., electricity, battery) or software electronics, however in other embodiments a power source or software electronics may be used.

[0034] In some embodiments, the vacuum source may be a vacuum pump capable of creating a vacuum within the device. In some embodiments, the vacuum source may include a chemical or other reactant that may react to increase or decrease pressure, which may create a pressure differential with the aid of a mechanical or other means driven by the reaction. In some embodiments, a chemical reaction may drive a mechanical actuation to create a pressure differential without a change in pressure based on the chemical reaction itself. In some cases, the vacuum source may be generated mechanically, for example, using a flexible dome, for example, as described herein.

[0035] Other examples of vacuum sources include syringe pumps, piston pumps, syringes, valves, venturi tubes, and manual (mouth) suction. In some embodiments, the vacuum source comprises a spring-loaded mechanism. A user may cock the spring-loaded mechanism during use of the device. In other embodiments, the spring-loaded mechanism may be supplied in a pre-cocked state prior to device actuation, and a user may release the mechanism, for example, by actuating a device actuator. In some embodiments, the vacuum source may comprise a bi-stable dome. The dome may be supplied in a buckled state prior to device actuation, and actuation of the device may pop the buckled dome to an expanded state to generate a vacuum.

[0036] In some embodiments, the vacuum may be created by a vacuum source without an external power source and / or an external vacuum source, for example, the vacuum source may be built into the device. For example, the vacuum may be created through a change in shape of a portion of the device (for example, using a shape memory polymer). As a specific example, a shape memory polymer may be molded to be flat at a first temperature (for example, room temperature) but curved at a second temperature (for example, body temperature), and when applied to the skin, the shape memory polymer may change from a flat shape to a curved shape, thereby creating a vacuum. As another example, a mechanical device may be used to create a vacuum. For example, a spring, coil, expanding foam (for example, from a compressed state), shape memory polymer, shape memory metal, or the like may be stored in a compressed or rolled state, which is released upon application to a subject, and then released (for example, unrolled, uncompressed, etc.), creating a vacuum mechanically.

[0037] Non-limiting examples of shape memory polymers and metals include nitinol, a composition of oligo(epsilon-caprolactone) diol and crystalline oligo(rho-dioxanone) diol, or a composition of oligo(epsilon-caprolactone) dimethacrylate and n-butyl acrylate.

[0038] In some embodiments, the device may include an indicator that provides an indication of the level of vacuum generated. In some embodiments, the indicator comprises a button or other element that retracts into the vacuum source (e.g., a vacuum chamber) due to receiving a vacuum generated by the vacuum source. In some embodiments, the indicator comprises a pressure gauge or other pressure gauge.

[0039] According to one aspect, to facilitate removal of fluid, the device includes an interface configured to contact the skin, the interface being conformable to the skin, e.g., the interface being capable of deforming to conform to the skin as the skin expands under vacuum. The interface may conform to the skin in an elastic (e.g., reversible) manner or in a plastic (e.g., irreversible) manner.

[0040] In some embodiments, the interface may be conformable to the skin due to the material from which it is made and / or due to the structural geometry of the device.

[0041] In some embodiments, the interface may be moveable relative to other components of the device, such as a rigid housing or rigid support that connects the interface to other components of the device.

[0042] In some embodiments, the interface is made from a flexible material such as silicone, including ECOFLEX 10, ECOFLEX 30, DRAGONSKIN 30, SMOOTH-SIL 940, SMOOTH-SIL 950, and SMOOTH-SIL 960, respectively, from SMOOTH-ON, INC. Any of these silicone materials may be combined with SLACKER (from SMOOTH-ON, INC.), a material that makes the silicone material softer and more tacky. In some embodiments, the interface is made from a thermoplastic elastomer, including a thermoplastic vulcanizate. Examples of thermoplastic elastomers include, but are not limited to, SANTOPRENE 111-35, SANTOPRENE 211-35, SANTOPRENE 111-45, and SANTOPRENE 211-45 from EXXONMOBIL or VERSAFLEX CL2242, VERSAFLEX CL2250, VERSAFLEX OM 1040X-1, and VERSAFLEX OM 1060X-1 from POLYONE. Examples of other possible flexible materials for the interface include, but are not limited to, polyurethanes, polystyrene / rubber block copolymers such as styrene-ethylene-butylene-styrene (SEBS), EPDM, and compressible foams (e.g., closed or open cell foams with a thin film coating to provide a seal against the skin).

[0043] In some embodiments, the structural geometry of the device may allow the interface to be conformable to the skin (e.g., in some embodiments, movable relative to other components of the device). For example, the device may include a region of reduced thickness connecting the interface to the remainder of the device, where the reduced thickness may act as a flexure region, e.g., a hinge, allowing movement of the interface relative to other portions of the device. Other approaches such as strategic removal of material (e.g., slits in the interface material), texturing of material, co-molding of parts (e.g., two rigid materials connected by a more flexible intermediate material, arranged in, e.g., concentric rings or layered stacks), forming of the interface from components with non-uniform material properties, or bellows design may also be used to achieve a flexure region. In some embodiments, the interface may be comprised of a single part or may be comprised of multiple parts. In some embodiments, the multiple parts may be movable relative to each other, e.g., via a pivoting relationship.

[0044] In some embodiments, the interface may be mated with a support, which may connect the interface to other components of the device, such as a vacuum source or a device housing.

[0045] In some embodiments, the support may be stiffer than the interface. In some embodiments, the interface is made of a first material and the support is made of a second material, the first material having a lower Young's modulus than the second material. However, in other embodiments, the support and the interface may be made of the same material.

[0046] In some cases, the Young's modulus of the first and / or second material may each independently be less than 30 GPa, less than 20 GPa, less than 10 GPa, less than 5 GPa, less than 3 GPa, less than 2 GPa, less than 1 GPa, less than 500 MPa, less than 300 MPa, less than 200 MPa, less than 100 MPa, less than 50 MPa, less than 30 MPa, less than 20 MPa, less than 10 MPa, less than 5 MPa, etc.

[0047] In some of these embodiments, the structural geometry of the device may allow the interface to be movable relative to the support. For example, an area of ​​reduced thickness or other geometry that provides a hinged arrangement may allow the interface to move relative to the support. In some embodiments, at least a portion of the interface may be thinner than at least a portion of the support.

[0048] The shape of the support may vary between different embodiments. In some embodiments, the support is cylindrical with vertically straight walls. In some embodiments, the support is funnel-shaped, with the walls tapering in the direction moving from the device opening into the device. In some cases, having a funnel-shaped support may help distribute the force against the skin and / or help promote desired skin bulging. The support may have other shapes as well.

[0049] In some embodiments, the interface may be rigid rather than flexible. The rigid interface may be provided with one or more features to aid in some of the effects described above, such as aiding in skin recruitment to allow for desired skin bulging, as well as distributing forces on the skin. In some embodiments, the rigid interface may be coated with a lubricant to facilitate movement of the skin underneath the interface. Examples of lubricants include, but are not limited to, yellow petrolatum, glycerin, propylene glycol, hydroxyethylcellulose, hydroxypropylmethylcellulose, silicones such as trisiloxane / dimethicone / cyclomethicone, fruit pectin, and extracts of aloe vera.

[0050] Materials for the rigid interface include, but are not limited to, photopolymerized methacrylates, polyethylene terephthalate(alcohol)esters (PET), polypropylene, polyethylene methylacrylate, polycarbonate, polystyrene, polyethylene, polyvinyl chloride, cycloolefin copolymers (COC), polytetrafluoroethylene, fluoropolymers, polyvinylidene chloride, polyimides, and polyesters. Combinations of these and / or other materials may be used in some embodiments.

[0051] In some embodiments, the skin may be recruited into the device as mentioned. In some cases, this may be determined by determining the area where the interface first contacts the skin, e.g., a first contact area, and then determining the area of ​​the skin where the interface contacts after removal of fluid due to application of reduced pressure, e.g., the second contact area may be larger than or encompass the first contact area in some cases.

[0052] In some embodiments, the rigid interface may be shaped to have any of the same shapes as discussed above with respect to the support portion of the device.

[0053] It should be noted that a flow activator need not be included in all embodiments, as the device may not necessarily employ a mechanism for triggering fluid ejection from a subject. For example, the device may receive fluid already ejected due to another cause, such as a cut or abrasion, fluid ejection due to a separate, independent device, such as a separate lancet, open fluid access, such as during a surgical procedure, etc.

[0054] If included, the flow activator may physically pierce, puncture, and / or scrape, incise the skin either laterally (e.g., slitting) or rotationally (e.g., coring), chemically ablate, corrode, and / or stimulate, emit and / or generate electromagnetic, acoustic, or other waves, or otherwise operate in other ways to cause fluid ejection from the subject. The flow activator may include, for example, a movable mechanism for moving a needle, or may not require movement to function. For example, the flow activator may include a jet injector or "hypodermic" that delivers fluid under pressure to the subject, a pneumatic system that delivers and / or receives fluid, a hygroscopic agent that adsorbs or absorbs fluid, a reverse iontophoresis system, a transducer that emits ultrasound or heat, radio frequency, and / or laser energy, and the like, any of which do not necessarily require movement of the flow activator to cause fluid ejection from the subject. In some embodiments, the flow activator may include one or more needles and / or blades.

[0055] It should be understood from the following description that the present device may have a needle deployment and retraction mechanism that is conceptually similar in various aspects to the devices disclosed in International Application No. PCT / US2017 / 043580, filed July 25, 2017, and U.S. Patent No. 8,821,412, filed November 19, 2012, the disclosures of which are incorporated herein by reference in their entireties.

[0056] In addition, the following documents, International Patent Application Publication Nos. WO 2010 / 101621, WO 2011 / 053787, WO 2011 / 053796, WO 2011 / 053788, WO 2011 / 094573, WO 2011 / 065972, WO 2011 / 088214, WO 2010 / 101626, WO 2011 / 163347, WO 2012 / 021792, WO 2012 / 021801, WO 2012 / 064802, WO 2011 / 088211, WO Nos. WO 2012 / 149143, WO 2012 / 149155, WO 2012 / 149126, WO 2012 / 154362, WO 2012 / 149134, WO 2016 / 123282, and WO 2018 / 022535 are each incorporated by reference in their entirety herein.

[0057] Turning to the figures, Figures 1A and 1B depict one exemplary embodiment of a support and interface of a fluid-receiving device. The support is cylindrical and has walls that are straight in the vertical direction, as seen in Figure 1B. The interface 10 has a horizontal portion 12 and a vertical portion 14. The interface is made of a flexible material such that the horizontal portion 12 is movable relative to the vertical portion 14 and is also movable relative to the support 20.

[0058] As seen in FIG. 2, the support 20 and the interface 10 may be integrated with a fluid-receiving module 30 to form a fluid-receiving device 1. FIG. 2 depicts the fluid-receiving device 1 in contact with the skin 8 of a subject. The interface 10 defines an opening 70 through which fluid is received from the subject into the device 1. The fluid-receiving module may contain various components. In the embodiment shown in FIG. 2, the fluid-receiving module 30 includes a vacuum source 40, a storage chamber 50, and a flow activator such as a needle assembly 60. A vacuum path 42 may provide fluid communication between the opening 70 and the vacuum source 40, and a storage path 52 may provide fluid communication between the opening 70 and the storage chamber 50. In some embodiments, a hydrophobic stop membrane 43 may be positioned between the storage chamber 50 and the vacuum source 40 to prevent fluid being withdrawn from the subject from entering the vacuum source 40.

[0059] 3A and 3B depict the interaction between the interface of the fluid receiving device and the skin under atmospheric and vacuum conditions, respectively. At atmospheric conditions, the horizontal portion 12 of the interface 10 is flush with the skin. Due to the flexibility of the interface 10, if the skin has irregularities, curves, or otherwise deviates from a flat plane, the interface 10 is able to conform to the shape of the skin and maintain a seal between the interface 10 and the skin.

[0060] As shown in Figure 3B, when the skin is subjected to a vacuum, the skin 8 tends to bulge (9) upward. Due to the material properties and shape of the interface 10, at least a portion of the interface moves relative to the support 20, allowing the skin to bulge. A portion of the horizontal portion 12 flexes upward relative to the support 20, allowing the skin to bulge and keeping the interface 10 in contact with the skin 8. The vertical portion 14 of the interface 10 may also flex relative to the support 20, allowing the skin to bulge.

[0061] Another illustrative embodiment of a support and interface of a fluid-receiving device is shown in Figures 4A, 4B, 5A, and 5B. The support 120 is cylindrical with walls that are vertically straight. As seen in most detail in Figures 4B and 5B, the interface 110 has a horizontal portion 112 and a rounded C-shaped portion 114 that transitions the interface from the support 120 to the horizontal portion 112 of the interface 110. The C-shaped portion 114 may act as a hinge that allows for inward and / or upward flexing of the horizontal portion 112 relative to the support 120 when a vacuum is applied. An opening 170 is defined by the interface. In some embodiments, the interface 110 is not axisymmetric. In some embodiments, the horizontal portion 112 may be tapered, for example, the horizontal portion 112 may become thinner toward the opening 170. In some embodiments, horizontal portion 112 may include features such as grooves or ridges, for example, to help direct blood from opening 170 toward a reservoir (also referred to herein as a storage chamber). Interface 110 may be made from a material that has a lower Young's modulus than the material of support 120. Interface 110 may be made from a flexible material, allowing interface 110 to move relative to support 120.

[0062] 6-9 show the support 120 and interface 110 of FIGS. 4A, 4B, 5A, and 5B integrated with the fluid-accepting module to form the fluid-accepting device 1. FIG. 9 is a cross-sectional view of the fluid-accepting device of FIG. 6 taken along line 9-9 of FIG. 8. The fluid-accepting module includes a vacuum source in the form of a vacuum valve 140, a reservoir 150, and a puncture assembly (or other flow activator deployment mechanism) including a needle assembly 60 and an actuation mechanism including a guide housing 168 having a pushing cap 62, a latch 66, a spring 64, and a firing ledge 68, as shown in FIG. 9. The spring 64 may be initially compressed prior to device actuation. The vacuum valve may be a flexible dome that may change shape when subjected to a force. The vacuum valve may be biased in some embodiments to return to a certain shape when the force applied to the vacuum valve is removed. In some embodiments, the force may be applied by a user. In some cases, the vacuum valve may return to a certain shape under a force applied by a pressure differential.

[0063] In operation, the user presses the device actuator 61, which in this embodiment is also part of the vacuum valve 140. Pressing the device actuator 61 pushes the push cap 62 downward, which causes the latch 66 to overcome the firing ledge 68, thus releasing the compressed spring 64 to expand. The spring 64 is coupled to the needle assembly 60 such that expansion of the spring 64 moves the needle assembly 60 in a deployment direction toward the opening 170 and toward the skin of the subject to pierce the skin of the subject. In some embodiments, when the spring 64 expands, it extends to a position past its rest length. Thus, the spring may be at a length longer than its rest length during piercing of the skin of the subject. After piercing the skin of the subject, the spring 64 may self-retract to its rest length, thereby moving the needle assembly 60 upwardly away from the opening 170. Needle retraction may serve to prevent subsequent inadvertent piercing of the skin.

[0064] In some embodiments, the device may also include a second spring 65. The second spring 65 may be coupled to the needle assembly 60. In some embodiments, the stiffness of the second spring 65 is less than the stiffness of the spring 64 of the actuation mechanism. The second spring 65 may act as a retraction actuator in the form of a retraction spring. The second spring 65 may be positioned between the housing 168 and the surface 121 and compressed between the housing 168 and the surface 121 during device actuation. In some embodiments, the second spring 65 is attached to the housing 168 and allowed to slide along the surface 121 during compression, for example.

[0065] The second spring 65 may contact a portion of the push cap 62 and the surface 121. In some embodiments, the puncture assembly, including the needle assembly 60, the latch 66, the push cap 62, the spring 64, and the housing 168, is movable relative to the support 120. Depressing the device actuator 61 moves the push cap 62 downward. In this illustrative embodiment, the springs 64, 65 are arranged as a spring in series. The downward movement of the push cap 62 compresses both springs 64, 65 due to the recoil force of the surface 121. The spring 65, which is less stiff than the spring 64, is compressed a greater distance than the spring 64 in this first stage of actuation.

[0066] As the second spring 65 is compressed, the entire assembly consisting of the push cap 62, spring 64, latch 66, and housing 168 translates downward as a unit toward the opening 170 until the bottom surface of the housing 168 contacts the subject's skin or contacts the surface 121, whichever occurs first. As the user continues to press down on the actuator 61 while the bottom surface of the housing 168 contacts the skin (or contacts the surface 121), the spring 64 continues to compress. The compression of the spring 64 allows the push cap 62 to move toward the latch 66 and firing ledge 68 until the push cap 62 contacts the latch 66, squeezing the arms of the latch 66 radially inward. As a result, the latch 66 overcomes the ledge of the housing 168, thus releasing the compressed spring 64 to expand. The spring 64 is coupled to the needle assembly 60 such that expansion of the spring 64 moves the needle assembly 60 in a deployment direction toward the opening 170 and toward the subject's skin to pierce the subject's skin. In some embodiments, the spring 64 is coupled to the pushing cap 62. In some embodiments, when the spring 64 expands, it extends to a position past its rest length. Thus, the spring may be at a length longer than its rest length during piercing of the subject's skin. After piercing the subject's skin, the spring 64 may self-retract to its rest length, thereby moving the needle assembly 60 upwardly away from the opening 170. Needle retraction may serve to prevent subsequent inadvertent piercing of the skin.

[0067] In some embodiments, due to the difference in stiffness between spring 64 and second spring 65, the expansion of spring 64 during deployment of needle assembly 60 may cause compression of second spring 65 against surface 121. As spring 64 self-retracts to its resting length, second spring 65 may also expand and move needle assembly 60 in the retraction direction. In some embodiments, the expansion of second spring 65 occurs only when the user releases actuator 61. However, in other embodiments, retraction may occur automatically without requiring user release of the actuator.

[0068] In some cases, due to the difference in stiffness, spring 65 may be significantly more compressed than spring 64. The mismatch in stiffness may be such that housing 168 will reach the skin after spring 64 is compressed to the point where pushing cap 62 disengages latch 66 from ledge 68 of housing 168. Disengagement of the latch results in extension of spring 64.

[0069] As discussed above, the device actuator 61 is also part of the vacuum valve 140. When a user applies force to the device actuator 61 to depress it, the application of force causes the vacuum valve to flex and move downward, decreasing the volume of the space 142 located below the vacuum valve 140. The decreasing volume of the space below the vacuum valve will initially create a pressure increase inside the device, but pressure will not build up inside the device due to the presence of the vent. Pressure can escape out through the vent. In some embodiments, the vent is a one-way vent. In some embodiments, the vent is in the form of a valve 154. The valve 154 may be a one-way valve such that airflow only moves from inside the device to outside the device and not the other way around.

[0070] For this and all other embodiments disclosed herein, examples of one-way valves include, but are not limited to, duckbill valves, ball check valves, umbrella valves, dome valves, Belleville valves, diaphragm check valves, swing check valves, stop check valves, lift check valves, in-line check valves, cross slit valves, or any other suitable valve that allows fluid to pass in only one direction.

[0071] In some embodiments, a user action may form part of the valve. For example, a gasket may be operably coupled to a device actuator. Prior to device actuation, the gasket may be in a closed position. Actuation of the device actuator may cause the gasket to open, allowing air to vent.

[0072] It should be understood that a valve may not be required in all embodiments, for example, in some embodiments, a vacuum valve may be preassembled within the device in a compressed state prior to device actuation.

[0073] In some embodiments, the vacuum valve 140 is biased to return to its original shape after application of force to the vacuum valve ceases. Thus, when the user stops pressing the device actuator 61, the vacuum valve 140 begins to move back to its original shape, thereby increasing the volume of the space below the vacuum valve. This increase in volume creates a vacuum that aids in the flow of fluid from the subject's punctured skin through the opening 170 and into the device.

[0074] In the illustrative embodiment of Figures 6-9, the device operates by deployment of needles into the skin prior to application of a vacuum to the skin.

[0075] The creation of a vacuum may cause the interface 110 to flex relative to the support 120 , for example at the C-shaped portion 114 .

[0076] Fluid entering the device flows towards the reservoir 150 via a flow path 152. In some embodiments, the reservoir 150 may be removable from the remainder of the device. The reservoir 150 may have a cap 151 to contain fluid collected in the reservoir 150 after the reservoir 150 is removed from the remainder of the device. The cap may be attached to the reservoir 150 via, for example, an integral hinge.

[0077] Reservoir 150 may be configured to removably couple to the device by fitting over flow passage 152. Reservoir 650 may remain coupled to and form a seal with flow passage 152, for example, via an interference fit.

[0078] In some embodiments, the reservoir is in the form of a collection tube. The reservoir may be sized and shaped for compatibility with other devices (e.g., may be commercially available from other parties), such as centrifuges, assay devices, or other analytical machines.

[0079] In some embodiments, the reservoir contains one or more substances or objects prior to activation of the device and prior to entry of fluid from the subject into the reservoir. For example, in some embodiments, the reservoir may contain sodium heparin, lithium heparin, balanced heparin, dipotassium EDTA, tripotassium EDTA, clot activators (such as silica), sodium citrate, sodium fluoride, sodium oxalate, citrate dextrose, gels for separation during centrifugation, mechanical barriers for separation during centrifugation, preservatives for nucleic acids (DNA, RNA), any combination of the above, and any other suitable objects or substances.

[0080] In some embodiments, the device may have two or more storage containers. In some embodiments, the device may require a user action to divert the incoming material from the body to either the first storage container or the second storage container. In other embodiments, the device may automatically direct the material toward the first or second storage chamber.

[0081] Another illustrative embodiment of a support and interface of a fluid receiving device is shown in Figures 10A and 10B. Support 220 is cylindrical with walls that are vertically straight. Interface 210 is horizontal and has rounded corners 212 at opening 270. Rounded corners 212 help to facilitate movement of the skin into opening 270 while also helping to reduce peak pressure applied to the skin.

[0082] Another illustrative embodiment of a support and interface of a fluid-receiving device is shown in Figures 11A and 11B. Interface 310 is horizontal and defines an opening 370. Support 320 has a funnel-shaped wall 322 that tapers in the direction away from opening 370 and moving into the device. Support 320 may, in some embodiments, include a mounting portion 324 for attaching support 320 to the remainder of the device, for example, to a vacuum source or a housing.

[0083] Another illustrative embodiment of a support and interface of a fluid-accepting device is shown in FIG. The support 420 is cylindrical with walls that are vertically straight. The interface 410 is L-shaped with a horizontal portion 412 and a vertical portion 414, and a neck portion 416 joins the horizontal portion 412 to the vertical portion 414. The neck portion 416 may have a width that is less than the width of the horizontal portion 412 and the vertical portion 414. The neck portion 416 may facilitate flexing of the horizontal portion 412 relative to the vertical portion 414 and / or relative to the support 420 during vacuum conditions.

[0084] Another illustrative embodiment of an interface of a fluid-receiving device is shown in Figures 13A and 13B. In this embodiment, the interface is not a flexible component that moves relative to the support or housing. Instead, the interface is a rigid component with a funnel-shaped wall 522 that tapers in the direction away from the opening 570 and moving into the device. The interface may include an attachment portion 524 that attaches to the remainder of the device, such as a housing or a vacuum source. A lubricant may be applied to the wall 522 to aid in skin bulging.

[0085] Another illustrative embodiment of a support and interface of a fluid-receiving device is shown in Figures 14A and 14B. Support 720 is a thin cylinder with walls that are vertically straight. Interface 710 is horizontal and has rounded corners 712 at opening 770. Rounded corners 712 may help to encourage movement of the skin into opening 770. In some cases, this may minimize pressure peaks against the skin.

[0086] An illustrative example of the flexible interface 710 of Figures 14A and 14B used with a fluid receiving device is shown in Figures 15A and 15B. In this embodiment, the flexible interface 610 is used with a device 2 having a pre-packaged vacuum, multiple microneedles, a snap dome deployment actuator that moves the microneedles to pierce the skin, and a retraction actuator, such as a retraction spring, that moves the microneedles away from the skin. A detailed description of device 2 can be found in International Application No. PCT / US2017 / 043580, filed July 25, 2017, and U.S. Patent No. 8,821,412, filed November 19, 2012.

[0087] Another illustrative embodiment of a support and interface of a fluid receiving device is shown in Figures 16A and 16B. Interface 810 is flexible and includes a first horizontal portion 811, a vertical portion 812, and a second horizontal portion 814. Support 820 has a wall that transitions from a vertical wall 822 to a curved dome 824.

[0088] Another illustrative embodiment of a fluid receiving device is shown in Figures 17A-17E.

[0089] Figure 17D is a cross-sectional view of the fluid-accepting device of Figure 17A taken along line 17D-17D of Figure 17C, and Figure 17E is a partial cut-away view of the fluid-accepting device of Figure 17A taken along line 17E-17E of Figure 17C.

[0090] The device includes an interface 910 and a support 920. In this illustrative embodiment, the interface 910 and the support 920 are made of the same material. As seen in FIG. 17D, the support 920 may have a greater thickness than the interface 910. The interface 910 may include a C-shaped portion 914 that allows the interface 910 to be movable relative to the support 920. The device may have needle deployment, retraction, and vacuum creation arrangements similar to those described with respect to the embodiment of FIGS. 6-9. In some embodiments, the placement of the valve 954 in the device 900 may be in a different location than that of the embodiment of FIGS. 6-9. In some embodiments, the valve 954 is located at the end of the device facing the reservoir 950. However, in other embodiments, the valve 954 may be located in the area of ​​the flow path 952 into the reservoir 950. In some embodiments, the valve may also be a separate part as shown, or it may be incorporated into a single part, such as a specific geometry being added to the vacuum valve, or it may be formed by the joining of two components, such as the addition of a specific geometry and specific joint pattern between the vacuum valve and the support.

[0091] In some embodiments, the device may include features that help direct the flow of blood toward the storage chamber. As seen in Figure 17E, the device includes a channel 915 that extends into the reservoir 950 from the device opening 970 toward the flow path 952. The channel 915 may be formed in the inner surface 911 of the interface 910.

[0092] In some embodiments, a portion of the interface 910 that transitions to the flow path 952 into the reservoir 950 may be shaped as a ramp 917 to aid in the flow of blood toward the reservoir 950. As a result, the interface 910 may be asymmetric. As seen in FIG. 17D , one side of the interface 910 may have a C-shaped portion 914 and the other side of the interface may be shaped as a ramp 917.

[0093] As discussed above, in some embodiments, the device actuator may be part of a vacuum source, such as the vacuum valve described above.

[0094] According to one aspect, in some embodiments, the fluid receiving device may have components that contact and compress the vacuum source, rather than directly contacting the user with the vacuum source. It should be understood that such components may in some embodiments aid in the compression of the vacuum source, for example, aiding in complete, uniform, and / or consistent compression of the vacuum source.

[0095] In some embodiments, the component that contacts and compresses the vacuum source is attached to a device actuator that is distinct from the vacuum source. In some embodiments, the device actuator has a stem and a user-contacting portion, also referred to herein as a button. In some embodiments, the user-contacting portion and the stem are fixed to one another such that movement of one portion moves the other and vice versa. When a user presses down on the user-contacting portion, the stem may also contact and compress the vacuum source.

[0096] In some embodiments, the fluid receiving device includes a shell that constrains the movement of the device actuator to assist in compressing the vacuum source by the device actuator. In some embodiments, the shell constrains the movement of the device actuator to linear movement. The shell may be made of a material that has a higher Young's modulus than the material of the vacuum source.

[0097] In some embodiments, the shell has an opening through which the device actuator travels. The stem of the device actuator may travel through the opening in the shell. The opening and stem may be complementarily sized and shaped to constrain the movement of the device actuator to linear movement.

[0098] In some embodiments, the fluid-receiving device includes a ratchet mechanism that allows movement of the device actuator relative to the shell in one direction while resisting movement of the device actuator in an opposing direction. The ratchet mechanism may facilitate full compression of the vacuum source by preventing the vacuum source from returning to its original shape until the vacuum source is fully compressed. In some embodiments, the ratchet mechanism includes a ratchet located on the device actuator and a pawl located on the shell, or vice versa. In some embodiments, the fluid-receiving device includes a lockout that prevents subsequent actuation of the device if it has been previously actuated. In some embodiments, such a lockout may be provided by the ratchet mechanism. In some embodiments, the ratchet mechanism may be located on a component other than or in addition to the device actuator.

[0099] An illustrative embodiment of a fluid receiving device 100 with a device actuator 71 distinct from the vacuum source 140 is shown in Figure 18. In this illustrative embodiment, the vacuum source is a flexible dome having a first shape prior to compression and a second shape during compression. The flexible dome is biased to return to its first shape when the flexible dome is no longer under compression.

[0100] The device actuator 71 includes a user-contacting portion 72 and a stem 74. The fluid-receiving device also includes a shell 21 having an opening 22 that receives the stem 74. The shell 21 may be made of a material having a higher Young's modulus than the material of the flexible dome 140. The stem 74 is movable relative to the shell 21 through the opening 22. The shell 21 may include a bottom perimeter 28 in some embodiments. The perimeter may help stabilize the device against the skin during use. In some embodiments, the shell 21 may include one or more window openings 29 through which the vacuum source 140 may be visualized by the user. A front perspective partial cutaway view of the fluid-receiving device is shown in FIG. 19, and a rear perspective partial cutaway view of the fluid-receiving device is shown in FIG. 20. In these partial cutaway views, a portion of the shell 21 is hidden from view to reveal more of the vacuum source 140 underneath.

[0101] When a user applies force to device actuator 71, the application of force causes the bottom of stem 74 to press against flexible dome 140, thus compressing flexible dome 140 by bending downward, as shown in Figures 21 and 22.

[0102] FIG. 23 is a partial cutaway view of the fluid receiving device prior to actuation of the device actuator, with a portion of the shell and a portion of the flexible dome hidden from view. The piercing assembly is also hidden from view for a clearer view of the inside of the flexible dome 140. In FIG. 23, no force is applied to the device actuator 71, and the flexible dome 140 is in its first original shape. As seen in FIG. 23, a volume of space 142 is located below the flexible dome 140. In FIG. 24, the device actuator 71 is pressed down by the user, causing a compression of the flexible dome 140, which reduces the volume of the space 142 below the flexible dome 140. Reducing the volume of the space 142 below the flexible dome 140 would initially create a pressure increase inside the device, but pressure would not build up inside the device due to the presence of the valve 155, shown in FIGS. 20 and 22. Pressure would escape out through the valve 155. Valve 155 may be a one-way valve that allows air under flexible dome 140 to exit when vacuum source 140 is compressed and prevents air from moving back in the opposite direction. In Figure 24, device actuator 41 has been pushed to its lowest position and flexible dome 140 is in its second shape.

[0103] When the user stops applying force to device actuator 71, flexible dome 140 may be free to return to its original shape. The return of flexible dome from the second shape to the first shape increases the volume of the space below flexible dome 140, thereby creating a vacuum below flexible dome 140.

[0104] The interaction between the device actuator, the shell, and the flexible dome is shown in the cross-sectional view of Figure 25. In this illustrative embodiment, stem 74 of device actuator 71 has a contact surface 79 that directly contacts flexible dome 140. However, in other embodiments, one or more intermediate components may be located between the stem and the flexible dome, and such intermediate components may transmit forces applied to the device actuator to the flexible dome.

[0105] In some embodiments, stem 74 and flexible dome 140 contact but are not attached to one another. However, in other embodiments, stem 74 and flexible dome 140 are attached to one another via, for example, an interference fit, heat staking, adhesive, mechanical interlock, or any other suitable attachment arrangement. Device actuator 71 slides within an actuator opening in shell 21, which rests over flexible dome 140.

[0106] According to one aspect, the shell and the actuator opening serve to constrain the movement of the device actuator to linear movement, which may aid in the aligned and uniform compression of the vacuum source. The actuator opening 22 of the shell 21 is shown in a perspective view of FIG. 26 and a top view of FIG. 27. In this illustrative embodiment, the actuator opening 22 is a plus sign shape. The shape of the actuator opening 22 corresponds to the shape of the stem 74 of the device actuator 71. A perspective view of the device actuator 71 is shown in FIG. 28 and a bottom view of the device actuator 71 is shown in FIG. 29. As seen in FIG. 29, the stem 74 also has a plus sign shape, comprised of a first fin 75, a second fin 76, a third fin 77, and a fourth fin 78. The stem 74 is sized and shaped to slide linearly through the actuator opening 22 of the shell 21, but is prevented from rotating or tilting within the actuator opening 22. Thus, the device actuator 71 may be constrained to linear movement.

[0107] In some embodiments, the stem 74 includes an assembly lockout 99 that is shaped to allow the stem 74 to be inserted into the actuator opening 22 during assembly, but to subsequently prevent removal of the stem 74 from the actuator opening 22. A close-up view of the interaction between the assembly lockout 99 and the shell 21 is shown in FIG. 30. The assembly lockout 99 is wedge-shaped, with a leading edge 95 (i.e., the point of the wedge) facing the bottom of the stem. When the device actuator 71 is pulled away from the shell 21, a trailing edge 97 of the assembly lockout 99 abuts against the inner surface 23 of the shell 21, thus preventing removal of the device actuator 71 from the shell 21. The stem 74 may have one or more assembly lockouts located on its fins. For example, the stem may have assembly lockouts on all four fins, on only two fins, e.g., two opposing fins or two adjacent fins, and / or on opposing sides of a fin.

[0108] 28, the device actuator 71 has a user contact portion 72 configured to be depressed by a user to actuate the fluid receiving device. In this illustrative embodiment, the user contact portion 72 includes a plurality of ribs 73 that may provide traction to assist the user in depressing the device actuator. The ribs in this illustrative embodiment are a plurality of concentric oval ribs. However, other arrangements of the ribs, such as linear ribs, are also possible.

[0109] In some embodiments, the surface area of ​​the user contact portion is larger than the cross section of the stem. The size of the surface area of ​​the user contact portion may help distribute the force applied by the user. In some embodiments, ribbing may add strength to the user contact portion to help distribute and withstand the applied force. In some embodiments, the vacuum source requires the application of a threshold amount of actuation force to generate the vacuum. The size of the surface area of ​​the user contact portion may allow the user to use more fingers or the entire palm, utilize more muscles in the arm and / or shoulder, and overcome the actuation force required to generate the vacuum.

[0110] According to one aspect, the fluid receiving device includes a ratchet mechanism that resists movement of the device actuator relative to the shell in a certain direction.

[0111] In one illustrative embodiment, the ratchet mechanism has a ratchet and a pawl, where the ratchet is attached to the stem of the device actuator and the pawl is attached to the shell. The pawl may be a cantilever extending from the shell. In some embodiments, the pawl may be integrally formed with the shell as a single monolithic component, i.e., the shell and the pawl are formed as a one-piece piece at the same time. As one illustrative example, the pawl may be formed by an integral hinge with the shell. In other embodiments, the pawl may be formed separately from the shell and then assembled to the shell via, for example, a mechanical hinge.

[0112] 31 shows a perspective view of a device actuator 171 having a user contact portion 172 and a stem 174. The stem 174 includes a ratchet 81 having a plurality of teeth. As shown in the bottom view of FIG. 32, the stem 174 includes four fins that form a plus sign shape: a first fin 175, a second fin 176, a third fin 177, and a fourth fin 178.

[0113] As shown in the side view of the device actuator 171 in Figure 33, the ratchet 81 is formed on two opposing fins, the first fin 175 and the third fin 177. On each side, the ratchet includes a first tooth 101 followed by a number of subsequent teeth 102. The ratchet also includes a first slot 91 toward the bottom of the stem (the end of the stem away from the user contact portion 172) and a second slot 92 toward the top of the stem (the end of the stem toward the user contact portion 172).

[0114] 34A-34G depict the sequence of interaction of the ratchet and pawl mechanism as the device actuator is moved relative to the shell. As seen in FIG. 34A, the shell 21 includes two opposing pawls 24 that interact with ratchets on the device actuator. In FIG. 34A, the device actuator 171 is in its initial position prior to device actuation. In the pre-actuation state, the pawls 24 are located in the first slot 91 at the bottom of the stem. In FIG. 34B, the user continues to press down on the device actuator 171, which moves downward relative to the shell 21, deflecting the pawls 24 downward as they contact the corners of the first slot 91. In FIG. 34C, the user continues to press down on the device actuator 171, and the pawls engage at teeth 102, which are shaped to prevent the device actuator 171 from moving back upward. Because flexible dome 140 is biased to return to its original uncompressed shape, when the user stops pushing the device actuator, without the ratchet, flexible dome 140 will revert back to its original shape, pushing the device actuator up and moving upward. If the user were to prematurely release the device actuator prior to full actuation (e.g., let go of the device actuator prior to pushing the device actuator all the way down until it is at its lowest), the flexible dome may not be fully compressed and therefore may not generate as much vacuum as it would have compared to full compression of the flexible dome. Thus, in preventing device actuator 171 from moving back upward, the ratchet teeth may help prevent insufficient generation of vacuum. Additionally, because the device actuator remains in a fixed position due to the ratchet holding the device actuator in place, the ratchet may provide a visual indicator to the user that actuation is incomplete.

[0115] Next, in FIG. 34D, the user pushes the device actuator 171 down until it is at its lowest position, thus completing actuation of the device. With the device actuator 171 in its lowest position, the pawl 24 enters the second slot 92, which releases the pawl 24 from the teeth 102 and allows the device actuator 171 to move back upward in the return direction. In FIG. 34E, the user has let go of the device actuator 171, and the device actuator 171 is pushed upward by the vacuum source reverting back to its original shape. As the corner of the second slot 92 pushes against the pawl 24, the pawl reverses its flexing direction and flexes upward instead of downward. In FIG. 34F, the device actuator 171 continues to be pushed upward by the vacuum source as the pawl 24 slides freely past the teeth 102 due to the reversed pawl flexing direction and the angle of the teeth 102. Finally, in Fig. 34G, pawl 24 reaches and engages first tooth 101, which has a reversed orientation relative to the other teeth 102. First tooth 101 is oriented in a manner that prevents device actuator 171 from moving downwardly relative to shell 21, thus preventing subsequent actuation of the device. The ratchet thus includes an actuation lockout feature that prevents more than one actuation of the device.

[0116] It should be understood that in other embodiments, no activation lockout feature is included and the device may be reused more than once.

[0117] In some embodiments, the ratchet and pawl arrangement acts as a detent to provide tactile and / or auditory feedback to the user during actuation of the device: the user may feel a vibration sensation and / or hear a clicking sound as the pawl slides against the teeth.

[0118] It should be understood that in some embodiments, the ratchet mechanism may be provided on a component other than or in addition to the device actuator. For example, in some embodiments, the ratchet mechanism may be provided between the support 200 and the guide housing 280. The ratchet teeth may be provided on the support and the pawl may be provided on the guide housing, or vice versa. With the ratchet mechanism between the support and the guide housing, a surface 291 may be attached to the flexible dome 140 in some embodiments to couple the ratchet mechanism with the flexible dome. The surface 291 may be attached to the flexible dome 140 by, for example, adhesive, UV welding, mechanical interlock, or any other suitable attachment method.

[0119] It should be understood that a ratchet is not required in all embodiments. In some embodiments, the device does not include a ratchet mechanism. For example, the device of FIG. 18 may include a ratchet in some embodiments and may not include any ratchet in other embodiments.

[0120] In the illustrative embodiment of the device actuator 171 of Fig. 31, the device actuator has a user contacting portion 172 with a different ribbing arrangement than that of the embodiment of Fig. 28. In the embodiment of Fig. 31, the user contacting portion 172 has a plurality of linear ribs 173 on either side of a central raised portion 179.

[0121] The device actuator 171 may include an assembly lockout 199 on one or more fins of the stem 174. In some embodiments, the assembly lockout may be attached to the stem via a hinge that allows rotational movement of the assembly lockout 199 when subjected to a force in a first direction, but does not allow rotational movement of the lockout when subjected to a force in a second direction opposite the first. In some embodiments, the hinge may be a living hinge.

[0122] According to one aspect, the device may include a puncture assembly configured to trigger release of the needle into the skin in response to contact with the skin. In some embodiments, the puncture assembly may be arranged in a floating arrangement in which a deployment actuator (e.g., a deployment spring) and the needle assembly may move together as a unit in a deployment direction toward the device opening during device actuation. The deployment actuator may be triggered to deploy the needle assembly when components of the puncture assembly contact the skin. The skin contact actuation arrangement may help promote successful puncture of the user's skin and prevent premature activation of the device. In some embodiments, the skin contact actuation may help promote consistency of needle insertion across users with different skin characteristics (e.g., users with highly compliant versus less compliant skin).

[0123] An exemplary embodiment of the puncture assembly of the device is shown in Figures 35-47. This puncture assembly may be used with any of the interface configurations described above. In some embodiments, this puncture assembly is positioned within a vacuum source such as the flexible dome shown and described above. In some embodiments, this puncture assembly is substituted for the device of the embodiment of Figure 9 or Figure 17D. In some embodiments, this puncture assembly is positioned within the flexible dome 140 of the embodiment of Figure 23.

[0124] 36, the piercing assembly may include a pushing cap 262 having an arm 263. The pushing cap may include a pushing surface 291. In some embodiments, during actuation of the device, the bottom inner surface of the flexible dome may contact the pushing surface 291 and impart a force onto the pushing surface 291 to initiate needle deployment.

[0125] In some embodiments, the puncture assembly may have a deployment actuator in the form of a deployment spring 264 and a retraction actuator in the form of a retraction spring 265. When in an extended state, the deployment spring 264 may be positioned between the push cap 262 and the latch 266. When in an extended state, the retraction spring 265 may be positioned between the guide housing 280 and a bottom portion of the support 200. In the illustrative embodiment of FIG. 36, the deployment spring 264 is a coil spring. However, other potential energy storage devices may also be used. In the illustrative embodiment of FIG. 36, the retraction spring 265 comprises a pair of helical cantilever arms extending from the support 200. However, other potential energy storage devices may also be used.

[0126] In some embodiments, the puncture assembly may have a guide housing 280 that receives the push cap 262, the latch 266, the deployment spring 264, the post 162, and the needle 164. The needle 164 may be configured to be movable through the guide housing 280 during extension of the deployment spring 264. The push cap 262, the latch 266, the deployment spring 264, and the post 162 may also be movable through the guide housing.

[0127] In some embodiments, the puncture assembly may have a support 200 and an interface 230. In some embodiments, the interface is made of a first material and the support ring is made of a second material, the first material having a lower Young's modulus than the second material. In some embodiments, the support 200 may provide structural rigidity to the less rigid interface 230. In some embodiments, the interface 230 may be made of any of the materials and / or have any of the properties discussed above with respect to the interface. In some embodiments, the support 200 includes one or more tabs 202 extending from a sidewall of the support. The interface 230 may include a corresponding slot 233 sized and positioned to receive the tab 202 of the support 200 and allow the support 200 and the interface 230 to interlock with each other. The tabs 202 may help reduce buckling of the sidewall of the interface 230 when the interface is pressed against the subject's skin and / or during vacuum release.

[0128] In some embodiments, at least a portion of the wall of the support may overlap at least a portion of the wall of the interface. In some embodiments, the interface may receive at least a portion of the support, e.g., the support may be at least partially nested within the interface. In the illustrative embodiment of FIG. 38, a portion of the wall 203 of the support 200 overlaps with a portion of the wall 234 of the interface 230.

[0129] 38, the interface 230 may include a circumferential groove 237 that receives the circumferential ridge 207 of the support 200 to interlock the support and the interface together. This interlock may help prevent the support 200 from sliding vertically against the interface and / or may be held in a position that allows the lower region of the interface 230 to flex.

[0130] The guide housing 280, deployment spring 264, needle 164, latch 266, and push cap 262 may be arranged in a "floating" fashion in which they move together as a unit in the deployment direction during device actuation toward the support ring 200 and device opening relative to interface 230 until guide housing 280 contacts the user's skin. Contact between guide housing 280 and the skin may trigger deployment spring 264 to stretch, deploying needle 164 to pierce the skin.

[0131] In one illustrative embodiment, the sequence of actuation of the puncture assembly is as follows: As discussed above, the puncture assembly may be physically located under a vacuum source, such as a flexible dome. The flexible dome is compressed, either by a user directly contacting the flexible dome or by a user interacting with an actuation button, such as the device actuator of the embodiment of FIG. 18. In turn, the inner surface of the flexible dome contacts the push surface 291 of the push cap 262. A force is transferred to both the deployment spring 264 and the retraction spring 265, causing both springs to compress. Because the retraction spring 265 is less stiff than the deployment spring 264, the retraction spring 265 is compressed a greater distance than the deployment spring 264. Compression of the retraction spring 265 allows the guide housing 280, latch 266, push cap 262, deployment spring 264, post 162, and needle 164 to move together in the deployment direction toward the device opening 170 until the bottom surface 385 of the guide housing 280 contacts the subject's skin.

[0132] Once the guide housing 280 contacts the subject's skin, the deployment spring 264 continues to be compressed as the user-applied force continues to be applied to the flexible dome and, in turn, the push cap 262. In some embodiments, the push cap may act as a latch release. The push cap 262 moves toward the latch 266, compressing the spring 264 until the contact surface 293 of the push cap 262 contacts the cam surface 268 of the latch arm 267, pushing the latch arm 267 radially inward until the latch arm 267 overcomes the ledge 381 of the guide housing 280. Once the latch arm 267 overcomes the ledge 381, the latch 266 is allowed to move in a deployment direction toward the device opening 170, thus allowing the deployment spring 264 to extend. The post 162 and needle 164 are attached to the spring 264. The expansion of the deployment spring 264 moves the needle 164 in a deployment direction toward the device opening 170 to pierce the user's skin. In some embodiments, the spring 264 is coupled to the pusher cap 262. In some embodiments, when the deployment spring 264 expands, it extends to a position past its rest length. Thus, the spring may be at a length longer than its rest length during piercing of the subject's skin. After piercing the subject's skin, the deployment spring 264 may self-retract to its rest length, thereby moving the needle assembly 60 upwardly away from the opening 170. Needle retraction may serve to prevent subsequent inadvertent piercing of the skin.

[0133] After needle deployment, the user releases the device actuator and / or the flexible dome and the force applied by the user to the flexible dome ceases. As a result, the retraction spring 265 is free to expand, moving the guide housing 280 and needle 164 in the retraction direction away from the device opening 170.

[0134] It should be appreciated that in some circumstances the retraction spring may tend to rotate during compression. For example, in the illustrative embodiment of the retraction spring 265 with a cantilevered spiral arm, the arm tends to rotate during compression. It should be understood that in some circumstances it may be desirable to prevent the retraction spring from imparting rotation to other components of the device. As discussed above, in some embodiments, the retraction spring 265 is positioned between the guide housing 280 and the bottom portion of the support 200 when in an extended state. In some embodiments, the retraction spring may not be attached to the guide housing 280 such that the two components are free to slide relative to one another. However, the retraction spring 265 may be attached to the support 200. For example, as the guide housing 280 is moved in a deployment direction toward the device opening during compression of the retraction spring 265, a surface of the guide housing slides against the retraction spring 265. In some cases, this non-attachment arrangement may help reduce the imparting of rotational movement of the retraction spring 265 to the guide housing 280.

[0135] In some embodiments, the device may include one or more features that help limit a certain movement of the retraction spring during compression and / or extension, hi some embodiments, the retraction spring may be shaped such that the arms of the retraction spring may tend to move radially outward during compression.

[0136] In some embodiments, the guide housing may include one or more features that help limit a certain travel of the retraction spring. In one illustrative embodiment, as shown in Figures 40 and 41, the guide housing 280 includes a notch 331 against which the arms of the retraction spring 265 slide during compression and / or extension of the retraction spring. The notch 331 helps to prevent the arms of the retraction spring 265 from sliding radially outward beyond a certain point.

[0137] In some embodiments, the support may include one or more features that help limit a certain travel of the retraction spring. In one illustrative embodiment, as shown in Figures 40 and 41, the support 200 may include rails 311 against which the arms of the retraction spring 265 slide during compression and / or extension. The rails 311 may help prevent the arms of the retraction spring from sliding radially outward beyond a certain point. Figures 45-47 also show the rails 311.

[0138] In some embodiments, a notch on the guide housing and a rail on the support cooperate to limit a certain travel of the retraction spring. An arm of the retraction spring may be bounded on one side by a notch and on another side by a rail.

[0139] It should be appreciated that in some situations it may be desirable to facilitate linear movement of the needle into and out of the skin. According to one aspect, the device may include one or more features that assist in guiding the movement of one or more components of the puncture assembly during deployment and / or retraction. In some embodiments, such movement guiding features may help to facilitate linear movement, for example, by limiting rotation and / or tilt of one or more components during deployment and / or retraction.

[0140] As discussed above, in some embodiments, the actuation sequence may begin with compression of the retraction spring 265, which allows the guide housing 280, latch 266, push cap 262, deployment spring 264, post 162, and needle 164 to move together in a deployment direction toward the device opening 170. In some embodiments, this deployment direction movement may be guided by an interaction between guide features on the guide housing 280 and corresponding guide features on the support 200. In one illustrative embodiment, the guide features are in the form of tracks 241, 242 on the support 200 and wings 281, 282 on the guide housing 280. The tracks 241, 242 are shaped to receive the wings 281, 282 and guide the linear movement of the guide housing 280, for example, during compression and / or expansion of the retraction spring 265. The tracks 241, 242 on the support may help to constrain the guide housing from rotating and / or tilting during movement.

[0141] As discussed above, in some embodiments, after the guide housing 280 reaches the user's skin, the push cap 262 may move toward the latch 266 and the deployment spring 264 may be compressed. In some embodiments, the device includes guide features that guide the movement of the push cap 262. In one illustrative embodiment, these guide features are in the form of tracks on the guide housing. As seen in the top view of the guide housing 280 in FIG. 44, in some embodiments, the guide housing 280 may include push cap tracks 285, 286 that receive the arms 263 of the push cap 262. The tracks 285, 286 guide the linear movement of the push cap, for example, during compression and / or expansion of the deployment spring 264. The tracks 285, 286 may help to restrain the push cap 262 from rotating and / or tilting during movement.

[0142] In some embodiments, the device may include guide features that help guide the movement of the latch. In one illustrative embodiment, these guide features are in the form of tracks on the guide housing. As seen in the top view of the guide housing 280 in FIG. 44, in some embodiments, the guide housing 280 may include latch tracks 287, 288 that receive the arms 367 of the latch 266. The tracks 287, 288 guide the linear movement of the latch, for example, during tensioning and / or extension of the deployment spring 264. In some embodiments, additional guide features may be provided in the form of tracks 289 on the guide housing that receive the additional arms 369 of the latch 266. The tracks 289 may further help guide the linear movement of the latch 266.

[0143] In some embodiments, a needle assembly, which may include one or more needles, may be attached to the latch 266 such that movement of the latch 266 moves the multiple needles. In one illustrative embodiment, the needles are attached to the latch via the posts 162. In some embodiments, the needles move through the guide housing 280 during deployment and / or retraction. As seen in the top view of the guide housing 280 in FIG. 44, the guide housing may include an opening 283 through which the posts 162 and / or needles may move.

[0144] It should be understood that in some embodiments, the guide features described above may not completely eliminate all rotation and / or tilt of a component, but rather may serve to limit the amount of rotation and / or tilt of a component.

[0145] As discussed above, in some embodiments, the retraction spring may be a pair of cantilevered spiral arms. In some embodiments, the retraction spring is integrated with the support such that the support and the retraction spring form a single monolithic component (e.g., molded as a one-piece part). However, in other embodiments, the retraction spring and the support are formed as separate pieces and later brought together during assembly.

[0146] 45-47, the retraction spring 265 includes two arms 231, 232, which are cantilevered spiral arms that are part of the support 200. As can be seen in FIG.

[0147] Because flexible dome 140 is biased to return to its original uncompressed shape, when the user stops pushing the device actuator, in some embodiments, without the ratchet, flexible dome 140 will reverse back to its original shape, pushing the device actuator up and moving it upward. If the user were to prematurely release the device actuator prior to full actuation (e.g., let go of the device actuator prior to pushing the device actuator all the way down until it is at its lowest), the flexible dome may not be fully compressed and therefore may not generate as much vacuum as it would have compared to full compression of the flexible dome. Thus, in preventing device actuator 171 from moving back upward, the ratchet teeth may help prevent insufficient generation of vacuum. Additionally, because the device actuator remains in a fixed position due to the ratchet holding the device actuator in place, the ratchet may provide a visual indicator to the user that actuation is incomplete.

[0148] However, it should be understood that in some embodiments, the flexible dome is used in a device without a ratchet. As an example, the ratchet may be eliminated.

[0149] According to one aspect, the flexible dome may include one or more features that aid in its performance. The flexible dome may be designed to be biased to return to its original configuration after being compressed. The force that urges the flexible dome to return to its original configuration is referred to herein as the return force of the flexible dome. It should be understood that the vacuum generated by the flexible dome may resist the return of the flexible dome to its original shape (e.g., if the force due to the vacuum exceeds the return force), which in turn may limit the amount of vacuum that can be generated by the flexible dome. A potential need is recognized in some embodiments for features that help facilitate the return of the flexible dome back toward its original shape.

[0150] It is noted that it is recognized that the flexible dome does not need to return completely to its original configuration in order to generate a sufficient amount of vacuum.

[0151] Also, it should be appreciated that iteratively iteratively returns to, or near, the original configuration.

[0152] Technical challenges using flexible domes designed to be manually compressed to generate a vacuum are recognized. It is understood that, on the one hand, in some cases, a chamber that is easy for a user to compress may not return to a sufficient degree to generate a sufficient vacuum (e.g., it may not have a shape / design / material properties that result in a strong return force), and, on the other hand, a chamber that would return fully or nearly fully may be excessively difficult for a user to fully compress. Without wishing to be bound by theory, it is recognized that in some cases, a rigid dome will have a strong return force but is difficult to fully compress, while a soft dome is easy to fully compress but has a weak return force (e.g., will be difficult to return to its original volume after being compressed). In some embodiments, the flexible dome may be configured to return to a predetermined position. It is recognized that such a dome may provide increased control over the level of vacuum generated.

[0153] Some embodiments described herein are directed to providing a flexible dome that is harder to compress during an initial phase of compression and easier to compress during a final phase of compression, which can result in a lower return force during the initial phase of return (e.g., when the force resisting return is lower because the magnitude of the vacuum generated at this point is smaller) and a higher return force during the final phase of return (e.g., when the force resisting return is higher due to the larger magnitude of the vacuum generated).

[0154] In some embodiments, the flexible dome may be arranged to be stiffer during the initial phase of compression and more compliant during the final phase of compression. In some embodiments, the dome includes features that encourage buckling of the dome as it is compressed, resulting in a dome that is stiffer during the initial phase of compression and more compliant during the final phase of compression. Conversely, the return force may be lower during the initial phase of return and higher during the final phase of return.

[0155] In some embodiments, the flexible dome includes a recessed shoulder that helps facilitate return movement of the flexible dome back towards its original shape. The recessed shoulder may facilitate buckling of the dome when the dome is compressed. It should be understood that in some embodiments, movement of the flexible dome back towards its original shape does not necessarily mean that the flexible dome actually achieves a full return to its original, uncompressed shape. In some embodiments, full return of the flexible dome back to its original, uncompressed shape is not achieved or required.

[0156] A perspective view of a flexible dome 140 is shown in FIG. 48. The dome has a wall 143 having a lower portion 141 and an upper portion 148. The wall 143 includes a recessed circumferential shoulder 144 between the upper and lower portions. The shoulder 144 may create a change in the concave direction of the wall 143. As seen in the side view of FIG. 49 and the cross-sectional view of FIG. 50, the lower portion 141 of the wall 143 may be curved such that the concave surface 147 of the lower portion 141 faces inwardly toward the longitudinal axis 149 of the dome. However, in the region of the shoulder 144, the concave surface 145 of the wall may face outwardly, away from the longitudinal axis 149 of the dome.

[0157] In some embodiments, the shoulder may be located at a height on the dome that is at the height of the top half of the dome. In some embodiments, the shoulder may be located at a height on the dome that is at the height of the top third or top quarter of the dome. In some embodiments, locating the recessed shoulder on the top half of the dome may arrange the flexible dome to be more stiff during the initial phase of compression and more compliant during the final phase of compression.

[0158] In some embodiments, the top of the flexible dome may include a depression. As seen in Figures 48 and 50, flexible dome 140 includes a circular depression 161 in top 146 of the dome.

[0159] In some embodiments, the thickness of the wall of the flexible dome may vary along different heights of the dome. In the illustrative embodiment of Figure 50, the lower portion 141 of the wall becomes thicker as it moves down from the shoulder 144 and away from the top 146 of the dome. However, in alternative embodiments, the wall thickness remains constant.

[0160] In some embodiments, the flexible dome does not include a shoulder that changes the concave direction of the wall. Alternative shapes for the flexible dome are shown in Figures 51 and 52, each of which does not include a recessed shoulder. The dome shapes shown in Figures 51 and 52 each include a recess at the top of the dome. However, in other embodiments, this recess may be omitted.

[0161] In some cases, the described flexible domes can be used to generate a vacuum to assist in receiving fluids or other substances, such as blood or interstitial fluid, from a subject, for example, from the skin and / or under the skin. However, the described flexible domes are not limited to only such applications. In other cases, the flexible domes as described herein may be used in any application in which it is desired that a vacuum be created. Examples include, for example, priming an oil pump, creating suction to attach objects together, or moving fluids or other substances from one location to another.

[0162] In some embodiments, needle deployment is triggered via a latch release, which releases a deployment spring from a compressed state to drive needle deployment. In some embodiments, such as in the illustrative embodiment of FIG. 38, the latch release is a distance-based latch release in that the latch release must travel a predetermined distance to reach and release the latch that holds the spring in its compressed state. A schematic of a distance-based latch release is shown in FIG. 53. A contact surface 293 must travel a predetermined distance to reach and release the latch 266. A deployment spring 264 is positioned between the contact surface 293 (or the device actuator itself or other component coupled to the device actuator) and the latch 266. During movement of the contact surface 293 (or otherwise during movement of the device actuator) toward the latch 266, the deployment spring 264 is compressed.

[0163] In an alternative embodiment, the latch release is a force-based latch release in that rather than requiring a minimum travel distance, a threshold actuation force must be applied to release the latch. A schematic diagram of a force-based latch release is shown in FIG. 54. When an actuation force F is applied to the push surface 291 (and / or device actuator), the latch 266 does not overcome the ledge 381' until the actuation force exceeds a threshold force. The threshold force may be determined by a number of factors. In some embodiments, the arrangement includes a ledge 381' having a sloped contact surface that contacts the latch 266' during application of the actuation force. In some embodiments, one factor affecting the threshold force may include the angle of the sloped contact surface. For example, a steeper angle may decrease the threshold force and a flatter angle may increase the threshold force. In some embodiments, one factor affecting the threshold force may include the amount of friction between the latch 266' and the ledge 381'. An increased amount of friction may increase the threshold force. In some embodiments, one factor that influences the threshold force is the stiffness of the cantilever arm 267' of the latch 266'. The expansion spring 264 is coupled to move with the push surface 291 (and / or the device actuator). The spring 264 begins to compress when an actuation force F is applied.

[0164] According to one aspect, latch characteristics that affect spring stiffness and threshold force are balanced against one another to control spring behavior. The spring stiffness and threshold force may determine the amount of compression the stiffness undergoes prior to unlatching. In some embodiments, the spring stiffness and threshold force for unlatching are selected to ensure that the spring extends a set distance beyond its rest length. For a given spring with a given stiffness, the latch may be tuned to release at a threshold force equal to or greater than the spring stiffness multiplied by the desired spring extension distance. Or, for a latch with a given threshold release force, the spring stiffness may be selected such that the threshold force is equal to or greater than the spring stiffness multiplied by the desired spring extension distance.

[0165] In some embodiments, the device includes a deployment actuator that moves the needle in a deployment direction toward the opening, and a retraction actuator that moves the needle in the opposite direction, i.e., a retraction direction away from the opening, hi some embodiments, the deployment actuator and the retraction actuator each act as a spring that can be operated to store potential energy, the release of which drives the movement of the needle.

[0166] In some embodiments, such as in the illustrative embodiment of FIG. 38, the deployment actuator and retraction actuator are arranged as springs in series. A schematic diagram is shown in FIG. 55. The deployment spring 264 is coupled to the needle assembly 164 such that the needle assembly 164 moves with the movement of the spring 264. The deployment spring 264 is positioned between the pushing surface 291 (and / or device actuator) and the guide housing 280 such that movement of the pushing surface 291 (and / or device actuator) relative to the guide housing 280 toward the interface 230 of the device compresses the deployment spring 264. The retraction spring 265 is positioned between the guide housing 280 and the interface 230 such that movement of the guide housing 280 toward the interface 230 compresses the retraction spring 265. Release of the retraction spring 265 from a compressed state moves the guide housing 280 in a retraction direction away from the interface 230, which in turn moves the needle assembly 164 in the retraction direction. The deployment spring 264 has a stiffness K2 and the retraction spring 265 has a stiffness K1. When the deployment and retraction springs are arranged in series, the springs are compressed simultaneously. In some embodiments, the stiffness K1 of the retraction spring 265 may be lower than the stiffness K2 of the deployment spring 264 to allow the retraction spring to be compressed to its target release distance before the deployment spring is compressed to its target release distance.

[0167] In an alternative embodiment, the deployment actuator and the retraction actuator are arranged as springs in parallel. A schematic diagram is shown in FIG. 56. Similar to the springs in the series arrangement, the deployment spring 264 is positioned between the pushing surface 291 (and / or device actuator) and the guide housing 280 such that movement of the pushing surface 291 (and / or device actuator) relative to the guide housing 280 towards the interface 230 of the device compresses the deployment spring 264. However, in contrast to the springs in the series arrangement, the retraction spring 265 is positioned between the pushing surface 291 (and / or device actuator) and the interface 230, rather than between the guide housing 280 and the interface 230. Thus, movement of the pushing surface 291 (and / or device actuator) towards the interface 230 compresses the retraction spring 265 in addition to compressing the deployment spring 264. In such an arrangement, the stiffness of the springs may be independent of each other. In some embodiments, the deployment spring only begins to compress once a retraction force is provided via the skin or a component in the device.

[0168] It should be appreciated that the device may be actuated by a variety of different actions / gestures, in some embodiments the device may be actuated by squeezing, twisting, pulling, pressing, pinching, jerking, or by any other suitable action.

[0169] In some embodiments, the user may actuate the device to retract and release the spring-loaded rod, or otherwise retract and release the spring-loaded rod, deploying the needle into the skin. In some embodiments, the user may cock the deployment mechanism to place the device in a state ready for actuation. For example, the user may compress or retract the spring until it reaches a latched state, and then actuate a device actuator to release the cocked spring. In other embodiments, the spring may be assembled in a pre-compressed or pre-extended state prior to any user interaction with the device, and the user may release the spring, for example, by actuating a device actuator.

[0170] In the illustrative embodiment above, the deployment and retraction actuators are springs. However, it should be understood that other arrangements for the deployment and / or retraction actuators are possible. For example, the deployment and retraction actuators may each include any number of suitable components, such as buttons, switches, levers, sliders, dials, compression springs, Belleville springs, compressible foam, snap domes, servos, rotary or linear electric motors, and / or pneumatic devices, or other suitable devices. Additionally, the deployment and retraction actuators may be the same type or different types of devices. Each actuator may operate manually, mechanically, electrically, pneumatically, electromagnetically, or other suitable modes of operation, and may or may not require user input for activation.

[0171] In some embodiments, the flexible dome may act as a retraction actuator, retracting the needle assembly away from the opening. Thus, the flexible dome may both generate a vacuum and retract the needle assembly. The needle assembly may be coupled to the flexible dome such that as the flexible dome retracts from the compressed state back towards its original uncompressed state, the needle assembly is pulled up in the retraction direction away from the opening along with the dome. In some embodiments, the needle assembly may be coupled to an inner surface of an upper portion of the dome. For example, surface 291 may be attached to the flexible dome by, for example, adhesive, UV welding, mechanical interlock, or any other suitable attachment method.

[0172] According to one aspect, the components of the puncture assembly are positioned to allow fluid flow into the outlet, which may lead to a reservoir. As seen in FIG. 38, the helical arms of the retraction spring 265 are in a position that does not block the outlet 253. In one illustrative embodiment, as seen in FIG. 37, the puncture assembly has an angular relationship to the outlet 253. The longitudinal axis 305 of the guide housing is at an angle to the longitudinal axis 307 of the outlet 253. In this illustrative embodiment, the angular relationship of the puncture assembly to the outlet places the arms of the retraction spring 265 in a position that does not block the outlet 253.

[0173] It should be understood that the device is not limited to the puncture assembly depicted in the figures. For example, in one embodiment, the puncture assembly comprises one or more needles coupled to the inside of an elastic dome. A user may press down on the dome to push the needle into the skin, and the dome may be biased to spring back to its initial position, thereby retracting the needle from the skin.

[0174] In another embodiment, the puncture assembly includes a snap dome in combination with an elastic dome, where one or more needles are coupled to the snap dome, a user may compress the elastic dome to bring the needles and snap dome into proximity with the skin, the snap dome may be actuated to invert, deploying the needles into the skin, and the elastic dome may be biased to spring back to its initial position, thereby retracting the needles from the skin.

[0175] In some embodiments, the puncture assembly includes an elastic dome with strategic imperfections that control the buckling behavior of the elastic dome, for example, a user may apply a force to the dome, the dome may eventually buckle due to the imperfections and drive the needle into the skin, and the dome may spring back to its initial position after removal of the user applied force.

[0176] In some embodiments, the puncture assembly may have an elastic dome with deployment and / or retraction behavior that is tailored through the use of non-uniform material properties or co-molding. For example, in some embodiments, the puncture assembly comprises a snap dome molded to the elastic dome.

[0177] Another illustrative embodiment of a fluid receiving device 600 is shown in FIG. 57, and the components of the fluid receiving device 600 are shown in an exploded view in FIG. 60. The device 600 may be largely similar to the previously described embodiment of FIG. 18. For example, the device may have a device actuator 690 distinct from the vacuum source 640, which may also be in the form of a flexible dome, as shown in the partial cutaway view of FIG. 58. The device actuator 690 may have a user contact portion 692 and a stem 694. The device may include a housing 621 having an opening 622 through which the stem 694 of the device actuator 690 may move. Fluid received by the device may be stored in a storage chamber 650. In some embodiments, the device 600 does not include a ratchet arrangement. However, in other embodiments, the device may include any of the ratchet arrangements described above in the previous embodiments.

[0178] As shown in Figures 59 and 60, the device may include a one-way valve 655, which may be in the form of an umbrella valve.

[0179] As shown in the illustrative embodiments of FIGS. 60 and 61, in some embodiments, the fluid receiving device may include a latch and spring assembly 665 including a latch release 766, a spring 664, and a latch 667. In some embodiments, the entire latch and spring assembly 665 may be integrally formed as a single part. In some embodiments, a subset of the latch and spring assembly is integrally formed as a single part (e.g., the spring 664 may be integrally formed with the latch release 766, or the spring 664 may be integrally formed with the latch 667), with the remaining components attached later. Any combination of these manufacturing arrangements may be used as well, for example, two of the three components are integrally formed with each other and the third is attached later.

[0180] As used herein, parts that are "integrally formed" with one another means that the parts are formed as one component such that they are formed from a single monolithic component, e.g., cast simultaneously as a single piece, as in die casting or injection molding, or cut from a single piece of material, as in stamping or die cutting.

[0181] The latch and spring assembly may be manufactured via injection molding, stamping, die casting, die cutting, or via any other suitable manufacturing process.

[0182] The latch and spring assembly 665 may be coupled to the needle 164 in any suitable manner. In the illustrative embodiment of FIG. 61 , the needle 164 may be mounted to a base 563, which may be attached to a latch 667 and / or a spring 664 of the latch and spring assembly 665. In some embodiments, a post 560 that is attached to the latch 667 and / or the spring 664 of the latch and spring assembly 665 may pass through a hole 561 in the base 563. The post 560 may be attached to the base 563 by heat staking, welding, adhesives, an interference fit, a snap fit, a mechanical interlock, a mechanical fastener, or any other suitable attachment method, and any combination of the above.

[0183] Similar to the previously described embodiments, the device 600 may include a guide housing 680 that may help guide the movement of the latch and spring assembly 665 during needle deployment and / or retraction. FIG. 62 shows the latch and spring assembly 665 received by the guide housing 680 in a state prior to spring compression and prior to needle deployment. The guide housing 680 may include a track 689 that is sized and positioned to receive the spring 664 to guide the linear movement of the spring 664, and thereby the needle 164 coupled to the spring 664, as the spring compresses and expands.

[0184] According to one aspect, in some embodiments, the fluid receiving device includes a positive stop configured to limit the needle distance to the interface of the device with the skin. It should be recognized that in some circumstances it may be beneficial to limit the needle travel distance to control the needle insertion depth into the skin. However, it should be understood that a positive stop is not required in all embodiments of the device.

[0185] In some embodiments, a positive stop that limits needle insertion is formed through interaction between the latch and spring assembly and the guide housing. The positive stop may limit the travel of the needle's penetrating end relative to a reference point on the device, such as the distal face of the guide housing.

[0186] As shown in Fig. 61, in some embodiments, the puncture assembly may include one or more pegs 550 that contact corresponding surfaces on the guide housing during spring extension to limit the distance the needle travels. Although two pegs are shown in the illustrative embodiment of Fig. 61, it should be understood that any number of pegs may be used, such as, but not limited to, three, four, five, six, seven, or eight pegs.

[0187] 63 and 64, where portions of the guide housing 680 are hidden, the guide housing may include a contact surface 551 positioned to contact the peg 550 as the spring 664 expands and as the needle 164 moves in the deployment direction. The contact between the peg 550 and the contact surface 551 creates a positive stop that prevents further distal movement of the needle 164 even if the spring 664 is not yet fully extended. In some embodiments, this positive stop may limit the travel distance of the distal end of the needle 164 beyond a distal surface 697 on the guide housing 680.

[0188] In some embodiments, the travel distance of the distal end of the needle past the distal surface on the guide housing is limited to less than or equal to 6, 5, 4, 3, 2, 1, 0.9, 0.8, 0.7, 0.6, 0.5, or 0.4 mm. In some embodiments, the travel distance of the distal end of the needle past the distal surface on the guide housing is limited to at least 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 2, 3, 4, or 5 mm. It should be understood that combinations of the above referenced ranges are also possible. For example, in some embodiments, the travel distance of the distal end of the needle past the distal surface on the guide housing is limited to 0.1-6, 0.5-5, 0.5-4, or 0.5-3 mm.

[0189] Peg 550 may be formed on and / or coupled to any suitable portion of latch and spring assembly 665, such as latch 667, spring 664, needle base 563, or post 560 (see FIG. 61). In the illustrative embodiment of FIG. 61, peg 550 extends from hub 553, which connects latch arm 603 and may also connect spring 664 to latch 667.

[0190] 63 and 64, the contact surface 551 is U-shaped. In other embodiments, the contact surface may be flat, convex, or any other suitable shape.

[0191] It should be appreciated that the location of the peg and contact surface may be reversed, such that the peg is on the guide housing and the contact surface is on the latch and spring assembly or on the needle base.

[0192] In other embodiments, the contact surface may be on a component other than the guide housing. For example, the contact surface may be on the support ring 200, the housing 621, or the interface 630.

[0193] In some embodiments, a positive stop may be created by the interaction between the latch release 766 and the latch 667. During spring extension, a surface on the latch may contact and abut against a surface on the latch release, limiting the extension of the spring and, as a result, the distance the needle can travel.

[0194] In some embodiments, a positive stop may be created by a primary interaction between the latch and spring assembly and the latch release and a secondary interaction between the latch release and the guide housing.

[0195] As with the previous embodiment, the guide housing 680 may also include a track 685 that receives and guides the linear movement of the arm 663 of the latch release 766, as shown in the top view of FIG. 66. The guide housing 680 may also include a latch track 687 that receives and guides the linear movement of the arm of the latch 667. Also as with the previous embodiment, the guide housing 680 may include a ledge 695 with which the arm of the latch 667 initially engages prior to device actuation, as shown in the partial cutaway views of FIGS. 66 and 68. Also as with the previous embodiment, the guide housing 680 may include wings 681, 682 that are received by the tracks on the support 200 to help restrain the guide housing from rotating and / or tilting during movement. Also, as with the previous embodiment, as seen in FIG. 67, the guide housing 680 may include a notch 635 that may help prevent the arm of the retraction spring 265 (see FIG. 45) of the support 200 from sliding radially outward beyond a certain point.

[0196] As shown in the embodiment of Figures 60-65, in some embodiments, the spring need not be a coil spring. In the illustrative embodiment of Figures 60-65, the spring 664 has an undulating shape (e.g., in a front-to-back manner that is a non-coil shape). A cross section of the spring 664 taken along line 65-65 of Figure 64 is shown in Figure 65. The spring 664 has a first end 660 at the cap 662 and terminates at a second end 661 at the hub 553. In the illustrative embodiment of Figure 65, the spring has a first beam 674, a second beam 675, a third beam 676, and a fourth beam 677. A first curve 671 joins a first beam 674 to a second beam 675, a second curve 672 joins the second beam 675 to a third beam 676, and a third curve 673 joins the third beam 673 to a fourth beam 677. In some embodiments, the concave surfaces of the continuous curves may face in opposite directions and the concave surfaces of the alternating curves may face in the same direction. As an example, the first curve 671 and the second curve 672 are continuous curves, while the first curve 671 and the third curve 673 are alternating curves. The concave surfaces of the first curve 671 and the third curve 673 may face in a first direction and the concave surface of the second curve 672 may face in an opposite second direction.

[0197] In some embodiments, the radii of curvature of the curves may be different. In some embodiments, the radii of curvature of successive curves may be different, while the radii of curvature of alternating curves may be the same. For example, in the illustrative embodiment of FIG. 65, the first curve 671 and the third curve 673 may have the same radii of curvature, while the second curve 672 may have a different radius of curvature than that of the first curve 671 and the third curve 673. In some embodiments, the second curve has a smaller radius of curvature than that of the first curve and that of the third curve. In other embodiments, the second curve has a larger radius of curvature than that of the first curve and that of the third curve.

[0198] It should be appreciated that in some embodiments, having springs with curves of different radii of curvature may allow the spring shape to have a longer beam within a constrained overall footprint. Without wishing to be bound by theory, it should be recognized that in some circumstances, a longer beam length of the spring may help to encourage greater overshooting past its rest position as the spring expands. Additionally, without wishing to be bound by theory, it should also be recognized that in some circumstances, curves of different radii of curvature may help to reduce strain at concentrated points.

[0199] For example, if the radius of curvature of the second curve 672 was increased but the position of the second curve remained unchanged, the lengths of the second beam 675 and the third beam 676 would potentially decrease. In the illustrative embodiment of FIG. 65, the second beam 675 and the third beam 676 have the same length. Also, as seen in FIG. 65, in some embodiments, the first end 660 of the spring may be attached to the cap 662 at an off-center location to allow the first beam 674 to have a longer length. In some embodiments, the second end 661 of the spring may be attached to the hub 553 at an off-center location to allow the fourth beam 677 to have a longer length.

[0200] In some embodiments, the spring beam may be oriented in a direction out of the plane of the latch and / or latch release. In some embodiments, the spring beam extends in a direction that is perpendicular to the width of the latch and latch release. It should be appreciated that such an arrangement can aid in fitting a long spring beam length within the constrained footprint of the latch and spring assembly.

[0201] In the illustrative embodiment shown in FIG. 61, the latch release 766 has a width W1 that spans its two arms 663. The latch 667 also includes a width W2 in the same direction that spans its two latch arms 603. Using the coordinate system shown in FIG. 61, the widths W1 and W2 extend in a direction along the X-axis. In contrast, the spring 664 generally undulates along the Y-axis in a direction that is perpendicular to the widths W1 and W2. As seen in FIG. 65, the beams 674, 675, 676, and 677 of the spring 664 generally extend along the Y-axis. The spring 664 includes a width W3 along the Y-axis that may span from the first curve 671 to the second curve 672. The width W3 of the spring 664 is perpendicular to the width W1 of the latch release and the width W2 of the latch. Without wishing to be bound by theory, in some embodiments, orienting the spring beam extension direction in a direction generally perpendicular to the latch and latch release width may allow for the use of longer spring beam lengths that are not physically constrained by the latch width or latch release width.

[0202] However, it should be understood that the specific orientation of the spring relative to the latch and latch release shown in the illustrative embodiment of Figure 61 is not a requirement for all embodiments. In other embodiments, the spring is oriented such that the spring beam extension direction is rotated 90 degrees relative to the illustrative embodiment of Figure 61 such that the spring generally undulates along the X-axis. In still other embodiments, the spring may be rotated any other suitable number of degrees relative to the illustrative embodiment of Figure 61.

[0203] The spring 664 may be manufactured via injection molding, stamping, die casting, die cutting, or via any other suitable manufacturing process. The spring 664 may be made from any suitable material, such as, but not limited to, plastic or metal.

[0204] In some embodiments, the device 600 may have a two-part housing 621. As shown in FIG. 60, the housing may be formed from a first housing portion 628 and a second housing portion 629. The first and second housing portions 628, 629 may be the same components that are molded to mate with one another to form a complete housing. FIG. 69 shows the assembled housing 621. The mating of the first housing portion 628 and the second housing portion 629 may form an opening 622 through which the stem 694 of the device actuator 690 may move.

[0205] 60, a reservoir 650, which in some embodiments may be in the form of a collection tube that may have an associated cap 651, may be configured to removably couple to the device by fitting over an extension 654 of the interface 630. The reservoir 650 may remain coupled to and form a seal with the extension 654, e.g., via an interference fit. The extension 654 may lead to an outlet 653 through which fluid flows into the reservoir 650. In some embodiments, the extension 654 is flexible, e.g., to facilitate easy attachment of the reservoir 650 to the extension 654.

[0206] It should be understood that in some embodiments, the latch and spring assembly 665 and guide housing 680 of FIGS. 60-67 may be replaced with a different latch and spring assembly and / or guide housing. While the illustrative embodiment shown in FIGS. 60-67 utilizes an integrated, one-piece latch and spring assembly 665, it should be understood that the latch and spring assembly may comprise separate spring, latch, and latch release components. The spring may comprise a coil spring in some embodiments.

[0207] One illustrative example of an alternative embodiment of a latch and spring assembly and associated guide housing that may be substituted for device 600 is shown in FIGS. 71-77. Latch and spring assembly 865 includes a coil spring 864, a latch release 862, and a latch 866, each of which may be formed separately and then attached together. Latch 866 may include a post 860 that may fit into some of the coils of spring 864 to attach the spring to the latch. Latch 866 may have a guide arm 869 that travels in a track 889 in guide housing 880, as shown in FIGS. 73-75.

[0208] 72-75 may also include a positive stop configured to limit needle travel. The positive stop may be created by interaction between the latch and the guide housing. The latch 866 may include a protruding peg 870 that may abut against a contact surface 851 of the guide housing.

[0209] As with the previous embodiment, as shown in the top view of FIG. 76, the guide housing 880 may also include a track 886 that receives and guides the linear movement of the arm 863 of the latch release 866. The guide housing 880 may also include a latch track 885 that receives and guides the linear movement of the arm 867 of the latch 866. Also as with the previous embodiment, as shown in the partial cutaway views of FIGS. 76 and 77, the guide housing 680 may include a ledge 881 with which the arm of the latch 866 initially engages prior to device actuation. Also as with the previous embodiment, the guide housing 880 may include wings 882 that are received by tracks on the support 200 to help constrain the guide housing from rotating and / or tilting during movement, and the guide housing may include a notch 831.

[0210] In some embodiments, the device may include an adhesive layer attached to the device interface configured to affix the interface to a surface of the skin. The adhesive layer may help form a seal between the device interface and the skin, which may facilitate the transfer of fluids from the body into the device (and / or the transfer of substances from the device into the body).

[0211] As discussed above, in some embodiments, the device interface is made from a flexible material. It should be understood that there are technical challenges associated with attaching an adhesive layer onto a flexible material or other low surface energy material.

[0212] In one illustrative embodiment, the adhesive layer is heat staked onto the device interface. In some embodiments, the adhesive layer that is heat staked to the device interface may form a seal between the adhesive layer and the device interface. In some embodiments, the heat staked adhesive layer may be able to withstand certain sterilization processes, such as gamma sterilization.

[0213] In some embodiments, the adhesive layer is a single-sided adhesive that includes an adhesive side and a non-adhesive backer side, hi some embodiments, the process of heat staking the adhesive layer to the device interface melts the backer to the device interface, thereby attaching the adhesive layer to the device interface.

[0214] In some embodiments, including some embodiments where the adhesive is heat staked to the device, the material of the backer is plastic. However, the backer is not necessarily limited to plastic in all embodiments. The backer may be made of any suitable material, including woven and nonwoven fabrics, plastics, polyphenylene ethers, elastomers, elastic polymer blend nonwoven fabrics, fiber reinforced adhesive transfer tape, knitted polyester tricot fabric, polyethylene, low density polyethylene, nylon, polyvinyl chloride foam, polyester, polyester spunlace, polyethylene / ethylene vinyl acetate, polyolefin, polyolefin foam, polyolefin foam coated wire, polypropylene, urethane, polyurethane, rayon nonwoven fabric, rayon woven fabric, spunlace nonwoven fabric, or thermoplastic elastomer film.

[0215] In some embodiments, including some in which the adhesive is heat staked to the device, the skin-side adhesive is made from an acrylate material. However, the adhesive is not necessarily limited to acrylate in all embodiments. The skin-side adhesive may be made from any suitable material, including acrylates, hydrocolloids, acrylic adhesives, silicone adhesives, hydrogels, pressure sensitive adhesives, contact adhesives, or the like. In some cases, the adhesive is selected to be biocompatible or hypoallergenic.

[0216] In some embodiments, the entire surface area of ​​the bottom interface may be covered with an adhesive layer, while in other embodiments, only a portion of the surface area of ​​the bottom interface is covered with an adhesive layer.

[0217] In some embodiments, the adhesive side of the adhesive layer may first be covered with a liner that the user peels off to expose the adhesive prior to use of the device.

[0218] In another set of embodiments, the device may be mechanically held to the skin, for example, the device may include a mechanical element such as a strap, belt, buckle, string, cord, elastic band, or the like. For example, a strap may be attached around the device to hold the device in place against the subject's skin. In yet another set of embodiments, a combination of these and / or other techniques may be used. As one non-limiting example, the device may be affixed to the subject's arm or leg using adhesive and a strap.

[0219] 57-60, adhesive layer 670 is attached to bottom 631 of interface 630, which may be flexible. Adhesive layer 670 may be attached via any other suitable arrangement, such as heat staked to interface bottom 631, or bonded or mechanically coupled.

[0220] In the illustrative embodiment discussed above, the needle deployment and retraction mechanism is used in a device in which a vacuum is applied to the skin after needle insertion into the skin. However, it should be understood that the needle deployment and retraction mechanism described above can also be used in a device in which a vacuum is applied to the skin before needle insertion into the skin. For example, if a flexible dome is used as the vacuum source, the puncture assembly can include an arrangement in which one or more needles are triggered to deploy after the flexible dome returns from a compressed state to its original uncompressed state or to a nearly uncompressed state. As another example, a pre-depressurized volume of space can be used as the vacuum source, in which case the device is configured to release the vacuum from the pre-depressurized volume prior to needle deployment.

[0221] As discussed above, the shape of the support may vary among different embodiments. Various illustrative embodiments of cross-sections of support shapes are shown in Figs. 78A-78M. It should be understood that these figures may show different shapes for only the distal portion of the support, i.e., the remaining portion of the support may be any suitable shape or have any suitable features. In other embodiments, the shapes shown in Figs. 78A-78M are the complete shape of the support, not just the distal portion. It should be understood that any of the shapes shown in Figs. 78A-78M may be used for any of the supports in the embodiments described above, including but not limited to the illustrative embodiments shown in the figures.

[0222] In FIG. 78A, the support 130 has a straight-walled cross-section with an aspect ratio greater than one.

[0223] In FIG. 78B, support 131 has an L-shaped cross-section.

[0224] In FIG. 78C, support 132 has a straight-walled cross-section with an aspect ratio of less than one.

[0225] In FIG. 78D, support 133 has a J-shaped cross-section.

[0226] In FIG. 78E, the support 134 has an L-shaped cross-section with rounded corners 158 .

[0227] In FIG. 78F, support 135 has a cross-section having a horizontal segment and a rounded section that transitions into a short vertical segment.

[0228] In FIG. 78G, the support 136 has an S-shaped cross-section.

[0229] In FIG. 78H, support 137 is funnel-shaped with straight walls.

[0230] In FIG. 78I, the support 138 is funnel-shaped with a proximal vertical section and a distal horizontal section.

[0231] In FIG. 78J, support 139 is funnel-shaped with curved walls having a shallow arc sweep of less than a quarter circle (approximately an eighth of a circle in some embodiments).

[0232] In FIG. 78K, the support 156 is funnel-shaped with curved walls having an approximate quarter-circle arc sweep.

[0233] In FIG. 78L, support 157 is funnel-shaped with curved C-walls.

[0234] As discussed above, the interface arrangement may vary among different embodiments. Various illustrative embodiments of interface arrangements are shown in Figures 79A-79F. It should be understood that any of the arrangements shown in Figures 79A-79F may be used in any of the embodiments described above, including but not limited to the illustrative embodiments shown in the figures.

[0235] In FIG. 79A, the interface comprises two layers 180, 181 of different materials.

[0236] In FIG. 79B, the interface comprises a continuous layer of material having one or more channel openings 183 that allow for the entry of substances from the body into the device.

[0237] In FIG. 79C, the interface comprises a membrane 184 with one or more channel openings 191 that allow for the entry of substances from the body into the device.

[0238] 79D, the interface comprises a membrane 190 attached to the side of the support 201 with a flexure that may allow the membrane to slide into the device opening 185 as the skin moves into the device opening (e.g., due to a vacuum). The membrane may have multiple channel openings 192.

[0239] In FIG. 79E, the interface comprises a membrane 187 with a ring of cushioning material 186 interposed between the support 201 and the membrane 187. In FIG.

[0240] In FIG. 79F, the interface comprises a membrane 188 with a ring of cushioning material 189 , the membrane 188 being interposed between the support 201 and the cushioning material 189 .

[0241] In some embodiments, the deformable structure may act as a needle deployment and / or retraction mechanism. In one set of embodiments, the deformable structure may move from a first position to a second position, and optionally, the deformable structure may be capable of reversibly moving from the second position to the first position, i.e., the deformable structure may be a reversibly deformable structure. In some cases, the first position is stable and the second position is unstable, while in other cases, both the first position and the second position are stable, respectively (i.e., the reversibly deformable structure is bi-stable). In such a stable position, no external force is required to maintain equilibrium, i.e., the position.

[0242] For example, the first position may be one in which the deformable structure is positioned such that the needles do not contact the skin, while the second position may be one in which the needles contact the skin and, in some cases, may pierce the skin. The deformable structure may be moved using any suitable technique, e.g., manually, mechanically, electromagnetically, using a servomechanism, or the like. In one set of embodiments, for example, the deformable structure may be moved from the first position to the second position by pressing a button, which moves the deformable structure (either directly or through a mechanism coupling the button with a support structure). Other mechanisms (e.g., dials, levers, sliders, etc. as discussed herein) may also be used in conjunction with or in place of the button. In another set of embodiments, the deformable structure may be moved automatically from the first position to the second position, e.g., in response to activation by a computer, in response to remote activation, after a period of time has elapsed, or the like. For example, in one embodiment, a servo connected to the deformable structure is electronically activated to move the deformable structure from a first position to a second position.

[0243] In some cases, the deformable structure may also be moved from the second position to the first position. For example, after a fluid has been delivered to and / or removed from the skin and / or under the skin, for example using a needle, the deformable structure may be moved, which may move the needle away from contact with the skin. The deformable structure may be moved from the second position to the first position using any suitable technique, including those described above, and the technique for moving the support structure from the second position to the first position may be the same or different as that for moving the support structure from the first position to the second position. In some cases, the deformable structure is reversibly deformable, i.e., the deformable structure is capable of returning from the second position to the first position.

[0244] In one set of embodiments, the device includes a deformable structure capable of driving needles into the skin, e.g., so that the needles can withdraw fluid from and / or from under the skin of a subject, and / or so that the needles can deliver fluid or other substances to a subject, e.g., to a location on the skin and / or under the skin of a subject. The deformable structure may be a structure that can be deformed using unassisted force (e.g., by a human pushing the structure) or other force (e.g., electrically applied force, mechanical interaction, or the like), but is capable of restoring its original shape after the force is removed or at least partially reduced. For example, the structure may spontaneously restore its original shape, or some action (e.g., heating) may be required to restore the structure to its original shape.

[0245] The deformable structure may, in some cases, be formed from a suitable elastic material. For example, the structure may be formed from plastics, polymers, metals, etc. In one set of embodiments, the structure may have a concave or convex shape. For example, the edges of the structure may be placed under compressive stress so that the structure "bends" outward to form a concave or convex shape. A person pushing against the concave or convex shape may deform the structure, but after the person stops pushing against the structure, the structure may be able to return to its original concave or convex shape, for example, spontaneously or with the use of other forces, as discussed above. In some cases, the device may be bi-stable, i.e., have two different positions in which the device is stable.

[0246] In one set of embodiments, the device may include a deformable structure that is movable between a first configuration and a second configuration. For example, the first configuration may have a concave shape, such as a dome shape, and the second configuration may have a different shape, such as a deformed shape (e.g., a "collapsed dome"), a convex shape, an inverted concave shape, or the like. The deformable structure may be moved between the first and second configurations manually, for example, by using a hand or finger to push against the flexible concave member, and / or the deformable structure may be moved using an actuator as described herein. In some cases, the deformable structure may be capable of spontaneously returning from the second configuration to the first configuration. However, in other cases, the deformable structure may not be capable of returning to the first configuration, for example, to prevent accidental repeated use of the deformable structure. The deformable structure may be a reversibly deformable structure in some embodiments, but in other embodiments this is not necessary. Additionally, in some cases, the deformable structure may (or may not) be a reversibly deformable structure, but the deformable structure may be moved from a first position to a second position using a first mechanism and moved from the second position to the first position or a third position using a second mechanism that is different from the first mechanism.

[0247] The deformable structure may be mechanically coupled to one or more needles (e.g., microneedles). The needles may be directly immobilized on the deformable structure, or the needles can be mechanically coupled to the deformable structure using a bar, rod, lever, leaf, spring, or other suitable structure. The needles are mechanically coupled to the deformable structure in some embodiments such that when the deformable structure is in a first configuration, the needles are in a first position, and when the deformable structure is in a second configuration, the needles are in a second position.

[0248] In some cases, relatively high velocities and / or accelerations may be achieved and / or needle insertion may occur in a relatively short period of time, for example, as discussed herein. The first and second positions may be separated by a relatively short distance in some cases. For example, the first and second positions may be separated by a distance of less than about 10 mm, less than about 9 mm, less than about 8 mm, less than about 7 mm, less than about 6 mm, less than about 5 mm, less than about 4 mm, less than about 3 mm, or about 2 mm, etc. However, even within such distances, in some embodiments, high velocities and / or accelerations, such as those discussed herein, may be achieved.

[0249] During use, the device may be placed in contact with the skin of a subject such that the recess or other suitable applicator area is adjacent to or in contact with the skin. By moving the deformable structure between the first and second configurations, due to the mechanical coupling, the deformable structure can move the needle to a second position within the recess or other applicator area and into contact with or through the skin of the subject.

[0250] In some embodiments, the device may also include a retraction mechanism capable of moving the needle away from the skin after the deformable structure reaches the second configuration. Retraction of the deformable structure may in some embodiments be triggered by the deformable structure itself, e.g., spontaneously returning from the second configuration to the first configuration, and / or the device may include a separate retraction mechanism, e.g., a spring, elastic member, crushable foam, or the like. However, in other cases, a different mechanism may be used to retract the deformable structure. For example, the deformable structure may be in the second configuration and, for example, withdrawn laterally from the skin without altering the configuration of the deformable structure.

[0251] The deformable structure can be made of any suitable material, such as stainless steel (e.g., 301, 301LN, 304, 304L, 304LN, 304H, 305, 312, 321, 321H, 316, 316L, 316LN, 316Ti, 317L, 409, 410, 430, 440A, 440B, 440C, 440F, 904L), carbon steel, spring steel, spring brass, phosphor bronze, beryllium copper, titanium, titanium alloy steel, chrome vanadium, nickel alloy steel (e.g., Monel 400, Monel K 500, Inconel 600, Inconel 718, Inconel x), or the like. 750, etc.), polymers (e.g., polyvinyl chloride, polypropylene, polycarbonate, etc.), composites or laminates (e.g., made of fiberglass, carbon fiber, bamboo, Kevlar, etc.), or the like.

[0252] The deformable structure may be of any shape and / or size. In one set of embodiments, the deformable structure is not planar, but has portions that can be in a first position (a "cocked" or pre-deployed position) or a second position (a "fired" or deployed position), optionally separated by relatively high energy configurations. In some cases, both the first and second positions are stable (i.e., the structure is bistable), but transformation between the first and second positions requires the structure to go through an unstable configuration.

[0253] In one embodiment, the deformable structure is a flexible concave member. The deformable structure may have, for example, a generally dome-like shape (e.g., as in a snap dome), be circular (without legs), or the deformable structure may have other shapes, such as oval, triangular (three legs), square (four legs), pentagonal (five legs), hexagonal (six legs), spider legs, star, cloverleaf (with any number of lobes, e.g., two, three, four, five, etc.), or the like. The deformable structure may have holes, dimples, or buttons in the middle in some embodiments. The deformable structure may also have a sawtooth disk or wave shape. In some cases, the needle may be mounted on the deformable structure. However, in other cases, the needle is mounted on a separate structure that is driven or actuated in response to the movement of the deformable structure.

[0254] As used herein, "vacuum" generally refers to an amount of pressure below atmospheric pressure; thus, atmospheric pressure has a vacuum of 0 mmHg, i.e., the pressure is a gauge pressure, not an absolute pressure. For example, the vacuum may have a pressure of at least about 50 mmHg, at least about 100 mmHg, at least about 150 mmHg, at least about 200 mmHg, at least about 250 mmHg, at least about 300 mmHg, at least about 350 mmHg, at least about 400 mmHg, at least about 450 mmHg, at least about 500 mmHg, at least about 550 mmHg, at least about 600 mmHg, at least about 650 mmHg, at least about 700 mmHg, or at least about 750 mmHg below atmospheric pressure, i.e., a pressure that is reduced compared to standard atmospheric pressure. For example, a vacuum pressure of 100 mmHg corresponds to an absolute pressure of approximately 660 mmHg (ie, 100 mmHg below 1 atm).

[0255] Vacuum may be applied to any suitable area of ​​skin, and in some cases, to an area of ​​skin over which the vacuum can be controlled. For example, the average diameter of the area over which the vacuum is applied may be kept less than about 5 cm, less than about 4 cm, less than about 3 cm, less than about 2 cm, less than about 1 cm, less than about 5 mm, less than about 4 mm, less than about 3 mm, less than about 2 mm, or less than about 1 mm. In addition, such vacuum may be applied for any suitable length of time. For example, vacuum may be applied to skin for at least about 1 minute, at least about 3 minutes, at least about 5 minutes, at least about 10 minutes, at least about 15 minutes, at least about 30 minutes, at least about 45 minutes, at least about 1 hour, at least about 2 hours, at least about 3 hours, at least about 4 hours, etc. Different amounts of vacuum may be applied to different subjects, in some cases, due to, for example, differences in the physical characteristics of the skin of the subjects.

[0256] In some embodiments, the flow activator may include one or more needles and / or blades. In some embodiments, the needles are microneedles. The needles may be arranged in a variety of different ways depending on the intended application.

[0257] For example, in some embodiments, the needle may have a length of less than or equal to about 5 mm, less than or equal to about 4 mm, less than or equal to about 3 mm, less than or equal to about 2 mm, less than or equal to about 1 mm, less than or equal to about 800 micrometers, less than or equal to about 600 micrometers, less than or equal to about 500 micrometers, less than or equal to about 400 micrometers, less than or equal to about 300 micrometers, less than or equal to about 200 micrometers, less than or equal to about 175 micrometers, less than or equal to about 150 micrometers, less than or equal to about 125 micrometers, less than or equal to about 100 micrometers, less than or equal to about 75 micrometers, less than or equal to about 50 micrometers, less than or equal to about 10 micrometers, etc.

[0258] In some embodiments, the needle may have a largest cross-sectional dimension of less than or equal to about 5 mm, less than or equal to about 4 mm, less than or equal to about 3 mm, less than or equal to about 2 mm, less than or equal to about 1 mm, less than or equal to about 800 micrometers, less than or equal to about 600 micrometers, less than or equal to about 500 micrometers, less than or equal to about 400 micrometers, less than or equal to about 350 micrometers, less than or equal to about 300 micrometers, less than or equal to about 200 micrometers, less than or equal to about 175 micrometers, less than or equal to about 150 micrometers, less than or equal to about 125 micrometers, less than or equal to about 100 micrometers, less than or equal to about 75 micrometers, less than or equal to about 50 micrometers, less than or equal to about 10 micrometers, etc.

[0259] In some embodiments, the largest cross-sectional dimension of the needle is the width of the needle. In some embodiments, the largest cross-sectional dimension of the needle is the thickness of the needle. In some embodiments, the largest cross-sectional dimension of the needle is the diameter of the needle. Depending on the geometry of the needle, some or all of these terms (i.e., width, thickness, diameter) may be synonymous.

[0260] For example, some embodiments include needles with rectangular cross sections, which may have thicknesses and widths that are distinct from one another. Some embodiments include needles with circular cross sections, where the needle's largest cross-sectional dimension is the diameter of the circular cross section.

[0261] In some embodiments, the needles may have a rectangular cross-section with dimensions of 175 micrometers by 50 micrometers or 350 micrometers by 50 micrometers.

[0262] In one set of embodiments, the needle may have an aspect ratio of its length to its largest cross-sectional dimension of at least about 2:1, at least about 3:1, at least about 4:1, at least 5:1, at least about 7:1, at least about 10:1, at least about 15:1, at least about 20:1, at least about 25:1, at least about 30:1, etc.

[0263] It should be understood that references to "needles" or "microneedles" as discussed herein are examples and for ease of presentation only, and that in other embodiments, more than one needle and / or microneedle may be present in any of the descriptions herein.

[0264] As an example, microneedles such as those disclosed in U.S. Patent No. 6,334,856, issued Jan. 1, 2002 by Allen, et al., entitled "Microneedle Devices and Methods of Manufacture and Use Thereof," may be used to deliver and / or withdraw fluids (or other substances) from a subject. Microneedles may be hollow or solid and may be formed from any suitable material, e.g., metal, ceramic, semiconductor, organic, polymer, and / or composite. Examples include, but are not limited to, medical grade stainless steel, titanium, nickel, iron, gold, tin, chromium, copper, alloys of these or other metals, silicon, silicon dioxide, and polymers of hydroxy acids such as lactic and glycolic acid polylactide, polyglycolide, polylactide-co-glycolide, as well as polymers including copolymers with polyethylene glycol, polyanhydrides, polyorthoesters, polyurethanes, polybutyric acid, polyvaleric acid, polylactide-co-caprolactone, polycarbonates, polymethacrylic acid, polyethylenevinylacetate, polytetrafluoroethylene, polymethylmethacrylate, polyacrylic acid, or polyesters.

[0265] In some cases, more than one needle or microneedle may be used. For example, an array of needles or microneedles may be used, and the needles or microneedles may be arranged in an array in any suitable configuration, such as periodic, random, etc. In some cases, the array may have 3 or more, 4 or more, 5 or more, 6 or more, 10 or more, 15 or more, 20 or more, 35 or more, 50 or more, 100 or more, or any other suitable number of needles or microneedles. Typically, the microneedles will have an average cross-sectional dimension (e.g., diameter) of less than about 1 micron.

[0266] In one illustrative embodiment, the flow activator comprises an array of microneedles arranged in a 7.5 mm diameter circular pattern with 30 microneedles around the circumference, each 1 mm long and 0.350 mm wide.

[0267] One skilled in the art will appreciate that the needle may be aligned relative to the skin or other surface for these purposes, including, in one embodiment, introducing the needle into the skin at an angle other than 90 degrees relative to the surface of the skin, i.e., introducing the needle or needles into the skin in an oblique manner to limit the depth of penetration, however, in another embodiment the needle may enter the skin or other surface at approximately 90 degrees.

[0268] In some cases, the needles (or microneedles) are arranged such that the density of needles in the array is about 0.5 needles / mm 2 ~Approx. 10 stitches / mm 2 and in some cases the density is about 0.6 needles / mm 2 ~Approx. 5 stitches / mm 2 , about 0.8 stitches / mm 2 ~Approx. 3 stitches / mm 2 , about 1 stitch / mm 2 ~Approx. 2.5 stitches / mm 2, or the like. In some cases, the needles may be positioned in the array such that no two needles are closer together than about 1 mm, about 0.9 mm, about 0.8 mm, about 0.7 mm, about 0.6 mm, about 0.5 mm, about 0.4 mm, about 0.3 mm, about 0.2 mm, about 0.1 mm, about 0.05 mm, about 0.03 mm, about 0.01 mm, etc.

[0269] In another set of embodiments, the needles (or microneedles) may be selected such that the area of ​​the needle (determined by determining the area of ​​penetration or puncture on the surface of the subject's skin by the needle) allows for proper flow of fluids to or from the subject's skin and / or under the skin. The needles may be selected to have smaller or larger areas (or smaller or larger diameters) so long as the area of ​​contact of the needle with the skin is sufficient to allow for proper blood flow from the subject's skin to the device. For example, in one embodiment, the needles are at least about 500 nm in diameter, depending on the application. 2 , at least about 1,000 nm 2 , at least about 3,000 nm 2 , at least about 10,000 nm 2 , at least about 30,000 nm 2 , at least about 100,000 nm 2 , at least about 300,000 nm 2 , at least about 1 micron 2 , at least about 3 microns 2 , at least about 10 microns 2 , at least about 30 microns 2 , at least about 100 microns 2 , at least about 300 microns 2 , at least about 500 microns 2 , at least about 1,000 microns 2 , at least about 2,000 microns 2 , at least about 2,500 microns 2 , at least about 3,000 microns 2 , at least about 5,000 microns 2, at least about 8,000 microns 2 , at least about 10,000 microns 2 , at least about 35,000 microns 2 , at least about 100,000 microns 2 , at least about 300,000 microns 2 , at least about 500,000 microns 2 , at least about 800,000 microns 2 , at least about 8,000,000 microns 2 etc., in a combined skin penetration area.

[0270] Needle or microneedle may have any suitable length, and the length may depend on the application in some cases.For example, a needle designed to penetrate only the epidermis may be shorter than a needle designed to penetrate the dermis as well or extend under the dermis or skin.In some embodiments, needle or microneedle may have a maximum penetration into the skin of about 3mm or less, about 2mm or less, about 1.75mm or less, about 1.5mm or less, about 1.25mm or less, about 1mm or less, about 900 microns or less, about 800 microns or less, about 750 microns or less, about 600 microns or less, about 500 microns or less, about 400 microns or less, about 300 microns or less, about 200 microns or less, about 175 microns or less, about 150 microns or less, about 125 microns or less, about 100 microns or less, about 75 microns or less, about 50 microns or less, etc. In certain embodiments, the needles or microneedles may be selected to have a maximum penetration into the skin of at least about 50 micrometers, at least about 100 micrometers, at least about 300 micrometers, at least about 500 micrometers, at least about 1 mm, at least about 2 mm, at least about 3 mm, etc.

[0271] In one set of embodiments, the needle (or microneedle) may be coated. For example, the needle may be coated with a substance that is delivered when the needle is inserted into the skin. For example, the coating may consist of heparin, anticoagulants, anti-inflammatory compounds, painkillers, antihistamine compounds, etc., to aid in the flow of blood from the skin of the subject, or the coating may consist of drugs or other therapeutic agents, such as those described herein. The drugs or other therapeutic agents may be those used for localized delivery (e.g., at or adjacent to the area to which the needle or microneedle coated thereon is applied) and / or the drugs or other therapeutic agents may be those intended for systemic delivery within the subject.

[0272] In some cases, at least a portion of the fluid received by the device from the subject may be stored and / or analyzed to determine one or more analytes, e.g., markers for a disease state, or the like. Fluid withdrawn from the subject may be subjected to such uses. Fluid may be removed using any suitable technique, e.g., as discussed herein.

[0273] Thus, the device may, in one set of embodiments, involve the determination of a condition in a subject. A variety of sensors may be used, many of which are readily commercially available. In such cases, the bodily fluid received by the device may be analyzed, for example, as an indication of the subject's past, present, and / or future conditions, or to determine a condition external to the subject. The subject's condition to be determined may be one that is currently present in the subject and / or one that is not currently present, but to which the subject is susceptible or otherwise at risk. The condition may be a medical condition, such as diabetes or cancer, or other physiological condition, such as dehydration, pregnancy, illicit drug use, or the like. Additional non-limiting examples are discussed herein. The determination may be made, for example, visually, tactilely, by odor, via instrumentation, etc.

[0274] In some cases, such fluids contain various analytes within the body that are important for diagnostic purposes, e.g., markers for various disease states, such as glucose (e.g., for diabetic patients); other exemplary analytes are ions, such as sodium, potassium, chloride, calcium, magnesium, and / or bicarbonate (e.g., to determine dehydration); gases, such as carbon dioxide or oxygen; H + (i.e., pH), metabolites such as urea, blood urea nitrogen, or creatinine, hormones such as estradiol, estrone, progesterone, progestin, testosterone, androstenedione (e.g., to determine pregnancy, illicit drug use, or the like), or cholesterol. Other non-limiting examples include insulin or hormones.

[0275] For example, fluid withdrawn from the skin of a subject often contains various analytes within the body that are important for diagnostic purposes, e.g., markers for various disease states, such as glucose (e.g., for diabetic patients); other exemplary analytes are ions, such as sodium, potassium, chloride, calcium, magnesium, and / or bicarbonate (e.g., to determine dehydration); gases, such as carbon dioxide or oxygen; H +(i.e., pH), metabolites such as urea, blood urea nitrogen, or creatinine, hormones such as estradiol, estrone, progesterone, progestins, testosterone, androstenedione (e.g., to determine pregnancy, illicit drug use, or the like), or cholesterol. Other examples include insulin or hormone levels. Still other analytes include, without limitation, high density lipoprotein ("HDL"), low density lipoprotein ("LDL"), albumin, alanine transaminase ("ALT"), aspartate transaminase ("AST"), alkaline phosphatase ("ALP"), bilirubin, lactate dehydrogenase, and the like (e.g., for liver function tests), luteinizing hormone or beta human chorionic gonadotropin (hCG) (e.g., for fertility tests), prothrombin (e.g., for coagulation tests), troponin, BNT or B-type natriuretic peptide, and the like (e.g., as cardiac markers), infectious disease markers such as for influenza, respiratory syncytial virus or RSV, or the like.

[0276] Other conditions / analytes that can be determined by the device include pH or metal ions, proteins, enzymes, antibodies, nucleic acids (e.g., DNA, RNA, etc.), drugs, sugars (e.g., glucose), hormones (e.g., estradiol, estrone, progesterone, progestin, testosterone, androstenedione, etc.), carbohydrates, or other analytes of interest. Other conditions that can be determined include pH changes that may indicate disease, yeast infection, periodontal disease at mucosal surfaces, oxygen or carbon monoxide levels that may indicate pulmonary dysfunction, and drug levels, both legal prescription levels of drugs such as Coumadin and illegal drugs such as cocaine or nicotine. Further examples of analytes include cancer-specific markers such as CEA and PSA, those indicative of disease such as viral and bacterial antigens, and autoimmune indicators such as antibodies to double-stranded DNA, indicative of lupus. Still other conditions include exposure to elevated carbon monoxide, which may be from an external source or may result from sleep apnea, excess heat (important in the case of infants whose internal temperature control is not fully self-regulating), or fever. Still other potentially suitable analytes include various pathogens, such as bacteria or viruses (e.g., coronaviruses, such as SARS-CoV-2), and / or markers produced by such pathogens. Thus, in an embodiment, one or more analytes in the skin or body may be determined in a manner that may be useful in determining the past, present, and / or future condition of a subject.

[0277] In some cases, a fluid or other substance received from a subject may be used to determine a condition external to the subject. For example, the fluid or other substance may contain a reactant capable of recognizing a pathogen or other environmental condition surrounding the subject, such as an antibody capable of recognizing an external pathogen (or pathogen marker). As a specific example, the pathogen may be Bacillus anthracis and the antibody may be an antibody against Bacillus anthracis spores. As another example, the pathogen may be Plasmodium falciparum (some species of which cause malaria) and the antibody may be an antibody that recognizes the malaria parasite. As yet another example, the pathogen may be a virus, such as a coronavirus (e.g., SARS-CoV-2), and the antibody may be an antibody capable of binding to at least a portion of the virus, such as a spike protein, an envelope protein, a membrane protein, or the like.

[0278] In some embodiments, in response to the determination of the fluid and / or analytes present or suspected to be present in the fluid, the microprocessor or other controller may display a suitable signal on the display. The display may also be used to display other information in addition to or instead of the above. For example, the device may include one or more displays that indicate when the device is being used or has finished, that indicate sampling of fluid from the subject is in progress and / or is complete or that a problem has occurred with the sampling (e.g., clogging or insufficient fluid collected), that analysis of analytes in the collected sample is in progress and / or is complete, that a proper amount of fluid has been delivered to the subject (or that an improper amount has been delivered and / or that fluid delivery is in progress), that the device may be removed from the subject's skin (e.g., upon completion of fluid delivery and / or withdrawal and / or upon suitable analysis, transmission, etc.), or the like.

[0279] However, a display is not a requirement, and in other embodiments, there may be no display, or other signals, such as light, smell, sound, touch, taste, or the like, may be used. Any of a variety of signaling or display methods associated with the analysis, including visual, smell, sound, touch, taste, or the like, may be provided in one set of embodiments. Signal structures and generators include, but are not limited to, displays (visual, LED, light, etc.), speakers, chemical release chambers (e.g., containing volatile chemicals), mechanical devices, heaters, coolers, or the like. In some cases, the signal structure or generator may be integral with the device (e.g., integrally connected with a support structure for application to the subject's skin, e.g., containing a fluid transporter such as a needle or microneedle), or the signal structure or generator may not be integrally connected with the support structure.

[0280] In some cases, the device may contain a sensor for determining the fluid and / or an analyte within the fluid. In some embodiments, the device may contain a reagent capable of interacting with an analyte contained or suspected to be present in the fluid from the subject, such as a marker for a disease state. As non-limiting examples, the sensor may contain an antibody capable of interacting with a marker for a disease state, an enzyme such as glucose oxidase or glucose 1-dehydrogenase capable of detecting glucose, or the like. The analyte may be determined quantitatively or qualitatively, and / or the presence or absence of the analyte in the withdrawn fluid may be determined, in some cases.

[0281] Additional non-limiting examples of sensors include, but are not limited to, pH sensors, optical sensors, ion sensors, colorimetric sensors, sensors capable of detecting the concentration of a substance, or the like, as discussed herein. For example, in one set of embodiments, the device may include an ion selective electrode. An ion selective electrode is an electrode that detects the concentration of a specific ion and / or K + , H+ , Na + , Ag + , Pb 2+ , Cd 2+ It may be possible to determine ions such as , , or the like. A variety of ion selective electrodes can be obtained commercially. As a non-limiting example, a potassium selective electrode may include an ion exchange resin membrane that uses the potassium channel valinomycin as the ion carrier within the membrane to provide potassium specificity. Those of skill in the art will recognize many suitable commercially available sensors, and the particular sensor used may depend on the particular analyte being sensed.

[0282] The sensor may be embedded in or integrally connected to the device, or may be remote but physically, electrically, and / or optically connected to the device, for example, to be able to sense a chamber in the device. For example, the sensor may be in fluid communication with the fluid withdrawn from the subject, directly, through a microfluidic channel, an analysis chamber, etc. The sensor may be able to sense an analyte, for example, suspected to be in the fluid withdrawn from the subject. For example, the sensor may not have any physical connection to the device, but may be positioned to detect the result of the interaction of electromagnetic radiation, such as infrared, ultraviolet, or visible light, directed towards a part of the device, for example, a chamber in the device. As another example, the sensor may be positioned on or in the device and may sense activity in the chamber by being optically connected to the chamber. Sensing communication can also be provided where the chamber is in fluidic, optical or visual, thermal, pneumatic, electronic, or equivalent communication with the sensor, so as to be able to sense the condition of the chamber. As an example, the sensor may be positioned downstream of the chamber, in a channel such as a microfluidic channel, or the like.

[0283] The sensor may be, for example, a pH sensor, an optical sensor, an oxygen sensor, a sensor capable of detecting the concentration of a substance, or the like. Other examples of analytes that the sensor may be used to determine include, but are not limited to, metal ions, proteins, nucleic acids (e.g., DNA, RNA, etc.), drugs, sugars (e.g., glucose), hormones (e.g., estradiol, estrone, progesterone, progestins, testosterone, androstenedione, etc.), carbohydrates, or other analytes of interest. Non-limiting examples of sensors include dye-based detection systems, affinity-based detection systems, microfabricated gravimetric analyzers, CCD cameras, optical detectors, optical microscopy systems, electrical systems, thermocouples and thermistors, pressure sensors, and the like. The sensor may include a colorimetric detection system in some cases, which may be external to the device or microfabricated within the device in some cases. Various non-limiting examples of sensors and sensor techniques include colorimetric detection, pressure or temperature measurements, spectroscopy such as infrared, absorption, fluorescence, UV / visible, FTIR ("Fourier transform infrared spectroscopy"), or Raman, piezoelectric measurements, immunoassays, electrical measurements, electrochemical measurements (e.g., ion-specific electrodes), magnetic measurements, optical measurements such as optical density measurements, light scattering measurements such as circular dichroism, quasi-electric light scattering, polarimetry, refractometry, chemical indicators such as dyes, or turbidity measurements including nephelometry.

[0284] In one set of embodiments, the sensors in the device may be used to determine the condition of the blood present in the device. For example, the sensors may measure the condition of analytes commonly found in blood, such as O2, K + , hemoglobin, Na +, glucose, or the like. As a specific, non-limiting example, in some embodiments, the sensor may determine the degree of hemolysis in blood contained within the device. Without wishing to be bound by any theory, it is believed that in some cases, hemolysis of red blood cells may cause the release of potassium ions and / or free hemoglobin into the blood. By determining the levels of potassium ions and / or hemoglobin (e.g., by allowing the device and / or blood to separate cells from plasma and then determining hemoglobin in the plasma using a suitable colorimetric assay), the amount of hemolysis or "stress" suffered by the blood contained within the device can be determined. Thus, in one set of embodiments, the device may indicate the utility of the blood (or other fluid) contained within the device, for example, by indicating the degree of stress or amount of hemolysis. Other examples of devices suitable for indicating the utility of the blood (or other fluid) contained within the device are also discussed herein (e.g., by indicating the amount of time blood has been contained within the device, the temperature history of the device, etc.).

[0285] In some embodiments, the analyte may be determined as an "on / off" or "normal / abnormal" status. Detection of the analyte may indicate, for example, that insulin is needed, a visit to the doctor to check cholesterol, that ovulation is occurring, that kidney dialysis is needed, that drug levels are present (e.g., particularly in the case of illicit drugs), or that they are too high / low (e.g., particularly important in geriatric care treatment in nursing homes). However, in alternative embodiments, the analyte may be determined quantitatively.

[0286] In one set of embodiments, the sensor may be a test strip, e.g., a test strip that may be obtained commercially. Examples of test strips include, but are not limited to, glucose test strips, urine test strips, pregnancy test strips, or the like. Test strips typically include bands, pieces, or strips of paper or other material and will contain one or more regions capable of determining an analyte, e.g., via binding of the analyte to a diagnostic agent or reactant that can interact with and / or associate with the analyte. For example, test strips may include various enzymes or antibodies, glucose oxidase and / or ferricyanide, or the like. Test strips may be capable of determining, e.g., glucose, cholesterol, creatinine, ketones, blood, protein, nitrite, pH, urobilinogen, bilirubin, white blood cells, luteinizing hormone, etc., depending on the type of test strip. Test strips may be used in any number of different ways. In some cases, test strips may be obtained commercially and inserted into the device, e.g., before or after drawing blood or other fluid from a subject. At least a portion of the blood or other fluid may be exposed to a test strip to determine the analyte, for example, in embodiments where the device uses a test strip as a sensor so that the device itself determines the analyte. In some cases, the device may be sold with a test strip preloaded, or the user may need to insert a test strip into the device (optionally removing and replacing the test strip between uses). In some cases, the test strip may form an integral part of the device that is not removable by the user. In some embodiments, after exposure to blood or other fluid drawn from a subject, the test strip may be removed from the device and determined externally, for example, using other equipment capable of determining the test strip, such as a commercially available test strip reader.

[0287] Other components may be present in the device in some embodiments. For example, the device may contain covers, displays, ports, transmitters, sensors, microfluidic channels, chambers, fluidic channels, and / or various electronics, for example, to control or monitor fluid transport into and out of the device, to determine analytes present in fluids delivered to and / or withdrawn from the skin, to determine the status of the device, to report or transmit information about the device and / or analytes, or the like.

[0288] In some aspects, the device may include channels, such as microfluidic channels, that can be used to move fluids within the device. In some cases, the microfluidic channels are in fluid communication with needles that are used to deliver and / or withdraw fluids to or from the skin. For example, in one set of embodiments, the device may also include one or more microfluidic channels, e.g., to contain fluids for delivery from a source of fluid to the needle and / or to withdraw fluids from the skin, e.g., to an analysis chamber within the device, to a reservoir for later analysis, or the like.

[0289] In some cases, more than one chamber may be present in the device, and in some cases, some or all of the chambers may be in fluid communication via a channel, such as, for example, a microfluidic channel. In various embodiments, various chambers and / or channels may be present in the device depending on the application. For example, the device may contain a chamber for sensing an analyte, a chamber for holding a reagent, a chamber for controlling temperature, a chamber for controlling pH or other conditions, a chamber for creating or relaxing pressure or vacuum, a chamber for controlling or attenuating fluid flow, a mixing chamber, a storage chamber for containing a fluid (e.g., withdrawn using a needle), a drug chamber, or the like.

[0290] For example, in some cases, the device may contain one or more chambers for holding or containing a fluid. In some cases, the chambers may be in fluid communication with one or more fluid transporters and / or one or more microfluidic channels. For example, the device may contain chambers for containing fluids withdrawn from a subject (e.g., for storage and / or later analysis), chambers for containing fluids for delivery to a subject (e.g., blood, saline, optionally containing drugs, hormones, vitamins, pharmaceuticals, or the like), etc.

[0291] In some cases, the storage chamber may contain a reagent or reactant capable of reacting with an analyte suspected to be present in the blood (or other fluid) entering the device, and in some cases the reactant may be determined to determine the analyte. In some cases, the determination may be made outside of the device, for example, by determining a color change or a change in fluorescence, etc. The determination may be made by a person or by an external device capable of analyzing at least a portion of the device. In some cases, the determination may be made without removing blood from the device, for example, from the storage chamber. (However, in other cases, blood or other fluid may first be removed from the device before being analyzed.) For example, the device may include one or more sensors (e.g., an ion sensor such as a K+ sensor, a colorimetric sensor, a fluorescent sensor, etc.) and / or contain a "window" that allows light to pass through the device. The window may be formed of glass, plastic, etc., and may be selected to be transparent, at least in part, to one or a range of suitable wavelengths depending on the analyte or condition to be determined. As a specific example, the entire device (or a portion thereof) may be mounted within an external device, and light from the external device may pass through or otherwise interact with at least a portion of the device (e.g., be reflected or refracted through the device) to determine analytes and / or reactants.

[0292] In some cases, the device may be designed such that portions of the device are separable. For example, a first portion of the device may be removed from the surface of the skin, leaving other portions of the device on the skin. In one embodiment, stops may also be included to prevent or control the depth to which the needle or microneedle (or other fluid transporter component) is inserted into the skin, for example to control penetration into the epidermis, dermis, etc. As another example, the device may include portions that are modular or removable from the device. For example, blood or other bodily fluids may be received by the device in a portion (e.g., containing a storage chamber) that can be removed from the device. For example, the removed portion may be stored, shipped to another location for analysis, or the like.

[0293] In one set of embodiments, the device contains a vacuum chamber, which is also used as a storage chamber to receive blood or other fluids drawn from the skin of a subject into the device.For example, blood drawn from a subject through or via a fluid transporter enters the vacuum chamber due to its negative pressure (i.e., because the chamber has an internal pressure less than atmospheric pressure) and can be optionally stored in the vacuum chamber for later use.The fluid collected by the device can then be analyzed in the device or removed from the device for analysis, storage, etc.

[0294] However, in another set of embodiments, the device may include separate vacuum chambers and storage chambers (e.g., a chamber for storing fluids such as blood from the skin of a subject). The vacuum chamber and storage chamber may be in fluid communication and may have any suitable arrangement. In some embodiments, the vacuum from the vacuum chamber may be used to at least partially withdraw fluid from the skin, which is then directed into the storage chamber for, e.g., later analysis or use, e.g., as discussed below. As an example, blood may be withdrawn into the device and flow toward the vacuum chamber, but fluid may be prevented from entering the vacuum chamber. For example, in certain embodiments, a material may be used that is permeable to gases but not to liquids such as blood. For example, the material may be a membrane, such as a hydrophilic or hydrophobic membrane with suitable porosity, a porous structure, a porous ceramic frit, a dissolvable interface (e.g., formed from a salt or polymer, etc.), or the like.

[0295] In some cases, the devices described herein may be single-stage or multi-stage. That is, the device may define a single unit, including one or more components integrally connected to each other that cannot be easily removed from each other by the user, or may include one or more components that are designed to be removed from each other and can be easily removed. As a non-limiting example of the latter, a two-stage device may be provided for application to the skin of a subject. The device may include a first portion designed to be in close proximity to the skin of a subject for the duration of the analysis, which may include an analysis area, a reservoir or other material for creating a vacuum or otherwise facilitating the flow of fluids or other substances to the analysis area, a needle or microneedle for accessing interstitial fluid or blood, or the like. A second stage or portion of the device may be provided that may initiate the operation of the device.

[0296] For example, a two-stage device can be applied to the skin of a user. A button or other component or switch associated with the second portion of the device can be activated by the subject, causing the insertion or equivalent of a needle or microneedle into the subject's skin. The second stage can then be removed, for example, by the subject, and the first stage can remain on the skin to facilitate analysis.

[0297] In another example, a two-stage device can be provided, where a first stage or portion contains visualization or other signal generating components and a second stage or portion contains components necessary to facilitate analysis, e.g., the second stage or portion can contain all components necessary to access bodily fluids, transport fluids to a site of analysis (if necessary), and the like, and that stage can be removed leaving only the visualization stage for viewing or otherwise analyzing a subject or other entity as described herein.

[0298] In yet another example, a two-stage device can include a first stage or portion that is applied to the skin of a subject and a second stage or portion that stores blood or another bodily fluid. The second stage can be removed and stored, shipped to another location for analysis, or the like.

[0299] In some embodiments, the parts of the device may be constructed and arranged to be easily connectable and / or detachable from each other, for example, by a subject. Thus, for example, a subject (or another person) may be able to connect parts (e.g., modules), assemble the device, and / or disconnect parts without the use of tools such as a screwdriver or tape. In some cases, the connection and / or disconnection can be performed while the device is attached to the skin. Thus, for example, a device may be applied to the skin of a subject, and after use, a part of the device may be removed from the skin of the subject, leaving the remaining part of the device in place on the skin. Optionally, a part may be replaced by another part of the device, which may be the same as or different from the part that is removed.

[0300] As an example, in one embodiment, the device may be fabricated to contain a first module and a second module that is constructed and arranged for repeated connection and disconnection to the first module. The first module may be used, for example, to deliver and / or withdraw fluid to a subject. For example, as discussed herein, the first module may contain a fluid transporter for delivering and / or withdrawing fluid to and / or under the skin of a subject. The fluid may optionally be analyzed in the first module and / or stored for later use, for example, in a collection chamber. After sufficient fluid is withdrawn, the first module may be removed, leaving the second module in place, and optionally replaced with a new first module for subsequent use (e.g., for subsequent delivery and / or withdrawal of fluid at a later time). However, in other embodiments, the second module may be removed, leaving the first module in place. Depending on the application, the removed module may be reused or disposed of (e.g., thrown away as trash), or the module may be shipped to another location for disposal and / or analysis, e.g., to analyze the fluid contained within the module, e.g., that has been withdrawn from the subject's skin. The module may be used once or multiple times before being removed from the device, depending on the application. Thus, as a non-limiting example, the device may contain a removable module that contains a removable fluid transporter (e.g., a needle or microneedle), e.g., a removable module for containing blood or another fluid that may be shipped to another location, or the like.

[0301] In some cases, any of the following components may be independently modular, and in some cases may be single-use or reusable, or even absent: pressure regulators such as vacuum chambers or other vacuum sources, actuators, activators, fluid transporters, fluid assays, sensors, fluid reservoirs (e.g., collection chambers), data storage or memory components, processors, detectors, power sources, transmitters, displays, or the like. As a non-limiting example, a module may be a single-use module (e.g., a module containing one or more of the following: fluid transporters, actuators, vacuum sources, fluid handling, fluid reservoirs, assay chemistry, etc.), or a module may be a reusable module (e.g., a module containing one or more of the following: detectors, processors, data storage devices, displays, transmitters, power sources, etc.). Alternatively, only a single unit (e.g., a fluid transporter, e.g., one or more needles or microneedles) may be single-use, and the remainder of the device may be reusable. Other combinations of these are also envisioned. In certain embodiments, the replaceable part within the device is required for the device to function, e.g., the device may not be able to function to deliver and / or withdraw fluid without the replaceable part being present within the device, hi one embodiment, the replaceable part is not a power source (e.g., a battery).

[0302] In one set of embodiments, the device or a part thereof (e.g., a module) is reusable. For example, the device may be used repeatedly (at the same location on the subject's skin or at different locations) to deliver and / or withdraw fluid to and / or under the skin of a subject. A device that is used repeatedly may be a single integral device and / or the device may contain one or more modules, such as those discussed above. For example, in some cases, between uses, a module may be removed and / or replaced from the device, for example, as discussed above.

[0303] In one set of embodiments, a device (or a portion thereof) as discussed herein may be shipped or transported to another location for analysis. For example, the device or module may be hand-carried, mailed, etc. In some cases, the device may include an anticoagulant or stabilizing agent contained within the device, e.g., in a storage chamber for the fluid. Thus, for example, a fluid such as blood drawn from the skin may be delivered to a chamber (e.g., a storage chamber) within the device, and then the device or a portion of the device (e.g., a module) may be shipped to another location for analysis. Any form of shipping or transportation may be used, e.g., via mail or hand delivery.

[0304] After the fluid is withdrawn into the device, the device or a part thereof may be removed from the skin of the subject, for example, by the subject or by another person.For example, the entire device may be removed, or the part of the device that contains the storage reservoir may be removed from the device and optionally replaced with another storage reservoir.Thus, for example, in one embodiment, the device may contain two or more modules, for example, a first module that can cause the withdrawal of fluid from the skin into the storage reservoir and a second module that contains a storage module.In some cases, the module that contains the storage reservoir may be removed from the device.

[0305] As another example, the device may include at least two modules that are manually separable from each other, including a first module that includes a vacuum chamber and a second module that includes other components such as those described herein. In some embodiments, the modules may be separable without the use of tools. For example, the second module may include one or more components such as a fluid transporter (e.g., a needle or microneedle), an applicator region such as a recess, a reversibly deformable structure such as a flexible concave member, a collection chamber, a sensor, a processor, or the like. As a specific example, the first module may be defined in whole or in part by a vacuum chamber, and the first module may be removed and replaced with an unused vacuum chamber during or between uses. Thus, for example, the first module may be inserted into the device when it is desired to remove blood or other bodily fluids from a subject, and may be used to optionally cause blood to be removed from the subject's skin.

[0306] In one set of embodiments, the first module may be generally cylindrical, and in some embodiments, the first module may be a Vacutainer. TM tube, vacuette TM The vacuum source may be a vacuum tube, or other commercially available vacuum tube, or other vacuum source as described herein. TM or Vacuette TM The tube may have a maximum length of about 75 mm or about 100 mm or less and a diameter of about 16 mm or about 13 mm or less. The device may also, in some embodiments, contain an adapter, e.g., a clamp, capable of holding or immobilizing such a tube on the device. Other examples of adapters are discussed in detail herein. In some cases, the device may be a Vacutainer. TM or Vacuette TM It may have a shape or geometry that mimics a tube, for example having the dimensions described above. The device, in some embodiments, is substantially cylindrically symmetric.

[0307] The withdrawn fluid may then be sent, for example, to a clinical and / or laboratory setting for analysis. In some embodiments, the entire device may be sent to a clinical and / or laboratory setting, however, in other embodiments, only a portion of the device (e.g., a module containing a storage reservoir containing fluid) may be sent to a clinical and / or laboratory setting. In some cases, the fluid may be shipped using any suitable technique (e.g., by mail, by hand delivery, etc.). In some cases, the subject may give the fluid to the appropriate party at a clinical visit. For example, a physician may prescribe a device as discussed above for use by the subject, and at the next visit, the subject may give the withdrawn fluid, for example, contained in the device or module, to the physician.

[0308] One side is the Vacutainer TM Tube or Vacuette TM The present invention is directed to an adapter that can be positioned within a device designed to contain a tube. TM or Vacuette TM The tube size has a maximum length of about 75 mm or about 100 mm or less and a diameter of about 16 mm or about 13 mm or less. In some cases, the adapter may be capable of immobilizing the device therein, for example, for subsequent use or processing. In some cases, the device may have a largest lateral dimension of about 50 mm or less and / or a largest vertical dimension that extends from the subject's skin when the device is applied to the subject of about 10 mm or less. The device may be contained within the adapter using any suitable technique, for example, using a clip, spring, clasp, band, or application of force to the device present within the adapter.

[0309] In one aspect, the device is relatively small in size. For example, in some embodiments, the device may have a largest lateral dimension (e.g., parallel to the skin) of about 25 cm or less, about 10 cm or less, about 7 cm or less, about 6 cm or less, about 5.5 cm or less, about 5 cm or less, about 4.5 cm or less, about 4 cm or less, about 3.5 cm or less, about 3 cm or less, about 2 cm or less, or about 1 cm or less. In some cases, the device may have a largest lateral dimension of about 0.5 cm to about 1 cm, about 2 to about 3 cm, about 2.5 cm to about 5 cm, about 2 cm to about 7 cm, etc.

[0310] In some embodiments, the device is relatively lightweight. For example, the device may have a mass of about 1 kg or less, about 300 g or less, about 150 g or less, about 100 g or less, about 50 g or less, about 30 g or less, about 25 g or less, about 20 g or less, about 10 g or less, about 5 g or less, or about 2 g or less. For example, in various embodiments, the device has a mass of about 2 g to about 25 g, a mass of about 2 g to about 10 g, a mass of about 10 g to about 50 g, a mass of about 30 g to about 150 g, etc.

[0311] Combinations of these and / or other dimensions are also possible in other embodiments. As non-limiting examples, the device may have a largest lateral dimension of about 5 cm or less, a largest vertical dimension of about 1 cm or less, and a mass of about 25 g or less, or the device may have a largest lateral dimension of about 5 cm or less, a largest vertical dimension of about 1 cm or less, and a mass of about 25 g or less, etc. As additional non-limiting examples, the device may have dimensions of 2.0 cm x 3.1 cm x 5.7 cm (height x width x length) or less, 2.5 cm x 3.5 cm x 6.0 cm or less, about 1.5 cm x 4.2 cm x 4.7 cm or less, 2.0 cm x 4.5 cm x 5.0 cm or less, 100 mm x 50 mm x 100 mm or less, 150 mm x 100 mm x 150 mm or less, 200 mm x 100 mm x 200 mm or less, etc.

[0312] In some embodiments, the device may be sized so that it can be worn and / or carried by the subject. For example, the device may be self-contained and not require any wires, cables, tubes, external structural elements, or other external supports. The device may be positioned on any suitable location of the subject, for example, on an arm or leg, on the back, on the abdomen, etc.

[0313] In some embodiments, the device may be connected to an external device for determining at least a portion of the device, fluid removed from the device, analytes suspected to be present in the fluid, or the like. For example, the device may be connected to an external analysis device and fluid may be removed from the device for later analysis, or fluid may be analyzed in situ within the device, for example, by adding one or more reactants to the device, for example, to a storage chamber or analysis chamber within the device. For example, in one embodiment, the external device may have a port or other suitable surface for mating with a port or other suitable surface on the device, and blood or other fluid may be removed from the device using any suitable technique, for example, using vacuum or pressure, etc. Blood may be removed by the external device and optionally stored and / or analyzed in some manner. For example, in one set of embodiments, the device may include an exit port for removing fluid (e.g., blood) from the device. In some embodiments, fluid contained in a storage chamber within the device may be removed from the device and stored for later use or analyzed outside of the device. In some cases, the exit port may be separate from the fluid transporter.

[0314] In one aspect, the device may be interfaced with an external device capable of determining an analyte contained within a fluid within the device, e.g., within a storage chamber as discussed herein. For example, the device may be mounted on an external holder, the device may include a port for transporting fluid out of the device, the device may include a window for interrogating the fluid contained within the device, or the like.

[0315] In some embodiments, the device may be connected to an external device for determining at least a portion of the device, fluid removed from the device, analytes suspected to be present in the fluid, or the like. For example, the device may be connected to an external analysis device and fluid may be removed from the device for later analysis, or fluid may be analyzed in situ within the device, for example, by adding one or more reactants to the device, for example, to a storage chamber or analysis chamber within the device. For example, in one embodiment, the external device may have a port or other suitable surface for mating with a port or other suitable surface on the device, and blood or other fluid may be removed from the device using any suitable technique, for example, using vacuum or pressure, etc. Blood may be removed by the external device and optionally stored and / or analyzed in some manner. For example, in one set of embodiments, the device may include an exit port for removing fluid (e.g., blood) from the device. In some embodiments, fluid contained in a storage chamber within the device may be removed from the device and stored for later use or analyzed outside of the device. In some cases, the exit port may be separate from the fluid transporter. For example, the exit port may be in fluid communication with a vacuum chamber, which may also serve as a fluid reservoir in some cases. Other methods for removing blood or other fluids from the device include, but are not limited to, removal using a vacuum line, a pipette, extraction through a septum instead of an exit port, or the like. In some cases, the device may also be placed in a centrifuge and subjected to various G-forces (e.g., a centripetal force of at least 50 g) to cause, for example, separation of cells or other material within the fluid in the device.

[0316] In some cases, the device may include a drug or therapeutic agent for delivery to the subject. For example, the drug may include an anti-inflammatory compound, an analgesic, or an antihistamine compound. Examples of anti-inflammatory compounds include, but are not limited to, NSAIDs (non-steroidal anti-inflammatory drugs), such as aspirin, ibuprofen, or naproxen. Examples of analgesics include, but are not limited to, benzocaine, butamben, dibucaine, lidocaine, oxybuprocaine, pramoxine, proparacaine, proxymethacaine, tetracaine, acetaminophen, acetylsalicylic acid, salicylic acid, diclofenac, NSAIDs, such as ibuprofen, or opioid drugs, such as morphine or opium, and the like. Examples of antihistamine compounds include, but are not limited to, clemastine, diphenhydramine, doxylamine, loratadine, desloratadine, fexofenadine, pheniramine, cetirizine, ebastine, promethazine, chlorpheniramine, levocetirizine, olopatadine, quetiapine, meclizine, dimenhydrinate, embramine, dimethicindene, dexchlorpheniramine, vitamin C, cimetidine, famotidine, ranitidine, nizatidine, roxatidine, or lafutidine. Other specific non-limiting examples of therapeutic agents that may be used include, but are not limited to, biologics such as erythropoietin ("EPO"), alpha-interferon, beta-interferon, gamma-interferon, insulin, morphine or other analgesics, antibodies such as monoclonal antibodies, or the like.

[0317] As mentioned, the device may include an anticoagulant or stabilizing agent to stabilize the fluid withdrawn from the skin. As a specific, non-limiting example, an anticoagulant may be used for blood withdrawn from the skin. For example, an anticoagulant or stabilizing agent may be present in a storage chamber of the device.

[0318] Examples of anticoagulants include, but are not limited to, heparin, citrate, oxalate, or ethylenediaminetetraacetic acid (EDTA). Other agents, such as stabilizing agents, such as solvents, diluents, buffers, chelating agents, antioxidants, binders, preservatives, antimicrobial agents, or the like, may be used in conjunction with or in place of the anticoagulant. Examples of preservatives include, for example, benzalkonium chloride, chlorobutanol, parabens, or thimerosal. Non-limiting examples of antioxidants include ascorbic acid, glutathione, lipoic acid, uric acid, carotene, alpha-tocopherol, ubiquinol, or enzymes such as catalase, superoxide dismutase, or peroxidase. Examples of antimicrobial agents include, but are not limited to, ethanol or isopropyl alcohol, azides, or the like. Examples of chelating agents include, but are not limited to, ethylene glycol tetraacetic acid or ethylenediaminetetraacetic acid. Examples of buffering agents include phosphate buffers, such as those known to those of skill in the art.

[0319] The device may be used in combination with analgesics or other agents that modify or suppress sensation. For example, analgesics such as benzocaine, butamben, dibucaine, lidocaine, oxybuprocaine, pramoxine, proparacaine, proxymethacaine, or tetracaine may be applied to the skin prior to or during fluid delivery and / or withdrawal, or another obscuring agent may be applied, such as an agent for causing a burning sensation, such as capsaicin or capsaicin-like molecules, such as dihydrocapsaicin, nordihydrocapsaicin, homodihydrocapsaicin, homocapsaicin, or nonivamide. Further examples of analgesics include, but are not limited to, acetaminophen, acetylsalicylic acid, salicylic acid, diclofenac, NSAIDs such as ibuprofen, or opioid drugs such as morphine or opium.

[0320] The pain relieving agent or other agent may be applied to the skin using any suitable technique, for example, using the device or separately. The pain relieving agent or other agent may be applied to the skin automatically or in response to activation of the device as discussed herein. For example, the pain relieving agent or other agent may be delivered to the skin (e.g., via a microfluidic channel from a chamber containing the pain relieving agent or other agent) prior to and / or after exposure of the skin to a fluid transporter as discussed herein. In some cases, the pain relieving agent or other agent may be sprayed onto the skin, for example, through a nozzle. In another embodiment, a sponge, gauze, swab, membrane, filter, pad, or other absorbent material may be applied to the skin (e.g., by the device) to apply the pain relieving agent or other agent to the skin, for example, to blood or other bodily fluids present on the skin. In some cases, a fluid transporter may pass through the material. For example, in response to application of the device to the skin, a portion of the device (e.g., a cover) may be removed, thereby exposing the skin to a material contained within the device containing the pain relieving agent or other agent to be applied to the skin. In some cases, an applicator such as a brush, pad, or sponge may be moved over the surface of the skin to apply the pain relieving agent or other agent to the skin. For example, the device may move the applicator across the surface of the skin.

[0321] In one aspect, the device may include a system for sanitizing at least a portion of a subject's skin, e.g., an area of ​​the skin where a fluid is delivered and / or withdrawn. The area may be sanitized at any suitable time. For example, the area may be sanitized before, during, and / or after delivery of fluid to and / or withdrawal of fluid from the subject's skin and / or under the skin. In some embodiments, the system for sanitizing the skin may be formed as an integral part of the device, however, in other embodiments, the system may be contained within a module that is connectable and / or removable to the remainder of the device (e.g., to other modules within the device). For example, the device may contain a sterilization module that, in various embodiments, can be optionally removed from the device and / or replaced with a new sterilization module.

[0322] As used herein, "sanitization" means that at least a portion of the microorganisms present on the surface of the skin are killed and / or inactivated (e.g., rendered non-infectious). Microorganisms that may be present include, for example, bacteria (e.g., those of the genera Propionibacteria, Corynebacteria, Staphylococcus, and / or Streptococcus), fungi, viruses (e.g., coronaviruses such as SARS-CoV-2), or the like. However, it should be understood that the skin may be "sanitized" without necessarily killing 100% of the microorganisms present on the skin in the area to be sanitized. For example, a sanitization system may be effective in killing and / or inactivating at least 25%, at least 50%, or at least 75% of the microorganisms, or by killing and / or inactivating the microorganisms by 1, 2, 3, or 4 logs, where a "log" is a 10-fold reduction in the number of active microorganisms.

[0323] In one set of embodiments, the device contains a fluid containing a disinfectant, and the fluid is applied to the skin. The fluid may be applied to the skin automatically or upon activation of the device as discussed herein. For example, the fluid may be delivered to the skin (e.g., via a microfluidic channel from a chamber containing the fluid) prior to and / or after exposure of the skin to a fluid transporter as discussed herein. In some cases, the fluid may be sprayed onto the skin, for example, through a nozzle. In another embodiment, a sponge, gauze, swab, membrane, filter, pad, or other absorbent material may be applied to the skin (e.g., by the device) to sanitize the skin. In some cases, a fluid transporter may pass through the material. As another example, a portion of the device (e.g., a cover) may be removed, thereby exposing the skin to a material contained within the device containing a disinfectant. In some cases, an applicator, such as a pad, brush, or sponge, may be moved over the surface of the skin to sanitize the skin. For example, the device may move the applicator across the surface of the skin.

[0324] In one set of embodiments, the disinfectant is a liquid, gel, or foam and / or is contained in a liquid, gel, or foam. The disinfectant may be any suitable agent capable of sanitizing the skin, such as peroxide (e.g., H2O2), bleach, alcohol (e.g., ethyl alcohol, isopropyl alcohol, etc.), n-propanol, triclosan, benzalkonium chloride, tincture of iodine (e.g., containing 2-7% potassium iodide or sodium iodide and elemental iodine dissolved in a mixture of ethanol and water), povidone-iodine (e.g., Betadine) chlorhexidine gluconate, or soap (e.g., common soap such as liquid soap), or the like. However, in another set of embodiments, the disinfectant may take the form of a source of radiation, e.g., ultraviolet radiation.

[0325] Another aspect is directed to a kit comprising one or more devices as discussed above. The kit may comprise a package or assembly comprising one or more of the devices as described herein and / or other components associated with such devices, for example, as described above. For example, in one set of embodiments, the kit may comprise a device and one or more compositions for use with the device. Each of the compositions of the kit, if present, may be provided in liquid form (e.g., in solution) or in solid form (e.g., dry powder). In some cases, some of the compositions may be configurable or otherwise processable (e.g., into an active form), for example, by the addition of suitable solvents or other species, which may or may not be provided in the kit. Examples of other compositions or components include, but are not limited to, solvents, surfactants, diluents, salts, buffers, emulsifiers, chelating agents, fillers, antioxidants, binders, bulking agents, preservatives, desiccants, antimicrobial agents, needles, syringes, packaging materials, tubes, bottles, flasks, beakers, dishes, frits, filters, rings, clamps, wraps, patches, containers, tapes, adhesives, and the like, for example, using, administering, modifying, assembling, storing, packaging, preparing, mixing, diluting, and / or preserving the composition or component for a particular use with respect to a sample and / or subject.

[0326] The kit may include instructions in any form provided in association with the device, in such a manner that a person skilled in the art would recognize that the instructions are associated with the device. For example, the instructions may include instructions for using, modifying, storing, shipping, repairing, disassembling, etc. the device. In some cases, the instructions may also include the use, modification, mixing, dilution, preservation, administration, assembly, storage, packaging, and / or preparation of the composition and / or other compositions associated with the kit. In some cases, the instructions may also include instructions for delivery and / or administration of the device, for example, to a subject, for example, for a particular use. The instructions may be provided in any form recognizable as a suitable means for containing such instructions, for example, written or published, oral, audio (e.g., by telephone), digital, optical, visual (e.g., videotape, DVD, etc.), or electronic communication (including internet or web-based communication) provided in any manner.

[0327] In some embodiments, the fluid-receiving device may include features generally directed to separating blood into plasma or serum and blood cell-rich fractions, e.g., under vacuum or reduced pressure. For example, the device may draw blood (or other suitable bodily fluid) into the device and / or through a membrane, such as a separation membrane. In some embodiments, the membrane is used to separate blood into a first fraction formed of plasma or serum and a second fraction enriched in blood cells.

[0328] In some cases, the device may be used to separate a relatively small amount of blood into plasma or serum and a fraction enriched in blood cells. For example, less than about 10 ml, less than about 5 ml, less than about 3 ml, less than about 2 ml, less than about 1.5 ml, less than about 1 ml, less than about 800 microliters, less than about 600 microliters, less than about 500 microliters, less than about 400 microliters, less than about 300 microliters, less than about 200 microliters, less than about 100 microliters, less than about 80 microliters, less than about 60 microliters, less than about 40 microliters, less than about 20 microliters, less than about 10 microliters, or less than about 1 microliter of blood may be received into the device and separated therein. The plasma or serum may then be withdrawn from the device, for example, using a needle to remove at least a portion of the plasma or serum, and may undergo various diagnostic or testing protocols, for example, for detection of infectious diseases, diabetes (e.g., sugar), AIDS (e.g., HIV), cancer (e.g., prostate specific antigen), or other indications. In some embodiments, the device may be relatively small, in contrast to machines typically used in plasma exchange (such as dialysis machines). For example, the device may be handheld or may be applied to the skin of a subject, for example, using an adhesive, as discussed below. The device may be self-contained in some embodiments, i.e., the device is thus capable of functioning to withdraw blood (or other bodily fluids) from a subject, separate it, and produce plasma or serum, without requiring external connections, such as an external source of vacuum, an external source of power, or the like. For example, a vacuum source within the device, e.g., a vacuum chamber, may be used to draw blood across a separation membrane and produce plasma or serum.

[0329] Moreover, in certain embodiments, the device is capable of effectively producing relatively small amounts of plasma or serum without requiring a relatively large amount of blood and / or without requiring a centrifuge to produce plasma or serum from the received blood. In some cases, at least about 30%, at least about 40%, at least about 50%, at least about 60%, at least about 70%, at least about 80%, or at least about 90% of the plasma or serum produced by the device may be received from the device, e.g., for use in subsequent testing or diagnosis. In contrast, in many prior art techniques where a sample of plasma or serum is required, e.g., for diagnostic or testing purposes, a relatively large amount of blood is drawn from a subject into a test tube (e.g., a Vacutainer). TM (Becton, Dickinson and company) or Vacuette TM(Greiner Bio-One GmBH) system) and the tube is then processed (e.g., via centrifugation) to separate the blood from the plasma or serum. A portion of the plasma or serum is then removed from the tube for diagnostic or testing purposes, however, the remaining portion of the plasma or serum in the tube is not needed for subsequent testing or diagnosis and is essentially discarded. Additionally, in some embodiments, serum may be produced without the use of an anticoagulant in the device, while in other embodiments, the device may contain an anticoagulant to produce plasma. In some embodiments, the membrane and / or storage chamber may contain an anticoagulant to produce plasma. Alternatively, if no anticoagulant is present in the device, the fluid flowing through the separation membrane into the storage chamber will be free of blood cells and will eventually coagulate in the storage chamber, thereby producing a liquid component also known as serum. The serum may be collected via aspiration or other suitable method out of the storage chamber, leaving the clot in the storage chamber. Thus, many of the embodiments described herein may be used to generate plasma or serum, depending on the presence or absence of an anticoagulant.

[0330] As mentioned, in one aspect, blood received from a subject into the device may be separated in the device to form plasma or serum by passing the blood or at least a portion thereof through a separation membrane or membrane that is permeable to fluids but substantially impermeable to cells. The separation membrane may be any membrane capable of separating the blood passing therethrough into a first portion (passing through the membrane) that is rich in plasma or serum and a second portion (rejected by the membrane) that is enriched in blood cells. In some cases, the separation membrane may have a separation effectiveness during use (separation effectiveness is the volume of plasma or serum passing through the membrane relative to the starting volume of whole blood) of at least about 5%, at least about 10%, at least about 20%, at least about 40%, at least about 50%, at least about 55%, or at least about 60%.

[0331] In one set of embodiments, the separation membrane is selected to have a pore size smaller than the average or effective diameter of blood cells contained within blood, including red blood cells and white blood cells. For example, the pore size of the separation membrane may be less than about 30 micrometers, less than about 20 micrometers, less than about 10 micrometers, less than about 8 micrometers, less than about 6 micrometers, less than about 4 micrometers, less than about 3 micrometers, less than about 2 micrometers, less than about 1.5 micrometers, less than about 1 micrometer, less than about 0.5 micrometers, etc. As specific non-limiting examples, the pore size may be from about 0.5 micrometers to about 2 micrometers or from about 0.5 micrometers to about 1 micrometer. In addition, in some embodiments, the separation membrane may have a thickness of less than about 1 mm, less than about 750 micrometers, less than about 500 micrometers, less than about 400 micrometers, less than about 350 micrometers, less than about 300 micrometers, less than about 250 micrometers, or less than about 200 micrometers.

[0332] The separation membrane may be formed from any suitable material. For example, in some embodiments, the separation membrane may be formed from a material that promotes thrombolysis or inhibits clot formation, such as polyester, and / or the separation membrane may be formed and / or coated with a biocompatible material or at least a material that does not cause an active clotting response in the blood to which the separation membrane is exposed. As specific, non-limiting examples, the separation membrane may be composed of or formed from glass (e.g., fiberglass), and / or polymers such as polycarbonate, polysulfone, polyethersulfone, polyarylethersulfone, polyvinylpyrrolidone, polypropylene, poly(2-methoxyethylacrylate), and / or nitrocellulose. In some embodiments, the membrane may include a copolymer, such as, for example, a graft copolymer (e.g., poly(propylene-graft-2-methoxyethylacrylate)) including any one or more of these polymers and / or other suitable polymers. In some cases, the separation membrane may be asymmetric and have different separation effectiveness depending on, for example, the way blood is passed across the separation membrane to generate plasma. Many such membranes can be readily obtained commercially, such as Pall Vivid plasma separation membranes (GF, GX, and GR) as well as other commercially available separation membranes.

[0333] During use, blood is moved toward the separation membrane using a suitable driving force to move the blood, e.g., a vacuum or other reduced pressure as discussed herein. A fluid portion of the blood is allowed to pass across the separation membrane to form plasma or serum on one side of the membrane, while other portions of the blood, e.g., red blood cells and white blood cells, are rejected by the membrane, thus forming a portion that is enriched in blood cells. For example, serum may be produced in the absence of any anticoagulant according to certain embodiments. One or both portions of the blood may be collected, e.g., in a suitable storage chamber, for further use, analysis, storage, etc., as discussed herein.

[0334] In some embodiments, the fluid receiving device may generally include features directed to a substrate for absorbing blood and / or other bodily fluids, such as a blood spot membrane. Thus, in some embodiments, blood spots may be generated on the blood spot membrane. In these cases, the channels in the device may be highly porous and may have a small volume relative to the volume of the blood spot membrane that may collect fluid. The blood spot membrane is used to collect fluid in some embodiments. The blood spot membrane is not used to separate cells / plasma in some cases (as opposed to the separation membranes discussed herein). Fluid may fill all or a portion of the blood spot membrane. A second hydrophobic membrane may be positioned over the collection membrane in some embodiments. Once the fluid contacts the hydrophobic membrane, fluid collection may cease. The blood spot membrane may remain in the device to dry and then be removed from the device. In some embodiments, the blood spot membrane may be removed from the device and dried outside of the device. In some cases, the membrane is not dried. If a vacuum is used to draw blood towards the blood spot membrane, the vacuum may, at least in some embodiments, be released prior to removal of the blood spot membrane from the device.

[0335] In one set of embodiments, the substrate is contained within a device for receiving blood from the skin of a subject. Examples of such devices capable of containing a substrate for absorbing blood and / or other bodily fluids, as well as details of such devices, are discussed in detail below.

[0336] In one set of embodiments, the substrate for absorbing blood may consist of, for example, paper, capable of absorbing blood or other bodily fluids received by the device. The substrate may be capable of partially or totally absorbing any blood (or other bodily fluids) it comes into contact with. For example, the substrate may consist of filter paper, cellulose filter, cotton-based paper, for example made from cellulose filters, cotton fibers (e.g., cotton threads), glass fibers, or the like. Specific non-limiting examples that are commercially available are Schleicher & Schuell 903 TM Or Whatman 903 TM Paper (Whatman 903 TM Sample collection paper) (Whatman International Limited, Kent, UK) or Ahlstrom 226 sample collection paper (Ahlstrom Filtration LLC, Mount Holly Springs, PA). In some embodiments, the paper may be one that is validated according to the requirements of the CLSI (Clinical and Laboratory Standards Institute) LA4-A5 consensus standard. However, other materials may also be used for the substrate for absorbing blood in place of and / or in addition to paper. For example, the substrate for absorbing blood (or other bodily fluids) may be comprised of gauze, cloth, cardboard, foam, foam board, paperboard, polymer, gel, or the like. In some cases, the absorbent substrate has a thickness of at least about 0.001 m. 2 / g, at least about 0.003 m 2 / g, at least about 0.005m 2 / g, at least about 0.01 m 2 / g, at least about 0.03m 2 / g, at least about 0.05m 2 / g, at least about 0.1m 2 / g, at least about 0.3m 2 / g, at least about 0.5m 2 / g, or at least about 1 m 2 / g. In some cases, the absorbent substrate may have a surface area of ​​about 100 g / m 2 ~about 200g / m 2or about 150 g / m 2 ~about 200g / m 2 may have a surface area of

[0337] Blood (or other bodily fluids) may be absorbed into the matrix such that the blood becomes embedded within the fibers or other materials forming the matrix and / or the blood becomes embedded within spaces between the fibers or other materials forming the matrix. For example, blood may be mechanically and / or chemically (e.g., via clotting and / or reaction with the fibers or other materials forming the matrix) retained within or on the matrix.

[0338] In some cases, the substrate may absorb a relatively small amount of blood, for example, less than about 1 ml, less than about 800 microliters, less than about 600 microliters, less than about 500 microliters, less than about 400 microliters, less than about 300 microliters, less than about 200 microliters, less than about 100 microliters, less than about 80 microliters, less than about 60 microliters, less than about 40 microliters, less than about 30 microliters, less than about 20 microliters, less than about 10 microliters, or less than about 1 microliter of blood may be absorbed into the substrate.

[0339] The substrate may be of any shape or size. In some embodiments, the substrate may be generally circular, while in other embodiments, other shapes are possible, e.g., square or rectangular. The substrate may have any suitable area. For example, the substrate may be large enough to contain only one spot of blood (e.g., of the volumes described above), or in some embodiments, more than one spot. For example, the substrate may be approximately 1 cm 2 Below, approximately 3cm 2 Below, approximately 5cm 2 Below, approximately 7cm 2 Below, approximately 10cm 2 Below, approximately 30cm 2 Below, approximately 50cm 2 Below, approximately 100cm 2 Below, approximately 300cm2 Below, approximately 500cm 2 Below, approximately 1,000cm 2 Less than or equal to 3,000 cm 2 It may have the following area:

[0340] In some embodiments, a "tab" or handle or other separate portion may be present on or adjacent to the substrate, e.g., to facilitate analysis and / or manipulation of absorbed blood or other bodily fluid. The handle may be any portion that may be used to manipulate the substrate. For example, the handle may be used to remove the substrate from the device for subsequent shipping and / or analysis, e.g., without requiring a person to touch the blood spot itself to manipulate the substrate. The handle may be formed from the substrate and / or a different material, e.g., plastic, cardboard, wood, metal, etc. In some cases, the handle may surround all or at least a portion of the substrate.

[0341] In certain embodiments, the matrix may include stabilizers or other agents, for example, to stabilize and / or treat blood within the matrix. Non-limiting examples of stabilizers include chelators, enzyme inhibitors, or dissolving agents. Examples of chelators include, but are not limited to, EDTA (ethylenediaminetetraacetic acid) or dimercaprol. Examples of enzyme inhibitors include, but are not limited to, protease inhibitors (e.g., aprotinin, bestatin, calpain inhibitors I and II, chymostatin, E-64, leupeptin or N-acetyl-L-leucyl-L-argininal, alpha-2-macroglobulin, pefabloc SC, pepstatin, PMSF or phenylmethanesulfonyl fluoride, TLCK, trypsin inhibitors, etc.) or reverse transcriptase inhibitors (e.g., zidovudine, didanosine, zalcitabine, stavudine, lamivudine, abacavir, emtricitabine, entecavir, apricitabine, etc.). Non-limiting examples of lysing agents include distilled water or guanidine thiocyanate.

[0342] The following are also each incorporated by reference in their entirety herein: U.S. Patent Application Nos. 62 / 842,303, 62 / 880,137, 62 / 942,540, 62 / 948,788, and 62 / 959,868.

[0343] Although aspects of the present disclosure have been described with reference to various illustrative embodiments, such aspects are not limited to the described embodiments. Thus, it is apparent that many alternatives, modifications, and variations of the described embodiments will be apparent to those skilled in the art. Thus, the embodiments as described herein are intended to be illustrative rather than restrictive. Various modifications may be made without departing from the spirit of the aspects of the present disclosure.

Claims

1. A device for receiving a fluid from a subject, the fluid being a bodily fluid, the device comprising: A device actuator; one or more flow activators configured to cause fluid to be expelled from the subject; a vacuum source comprising a flexible dome made from a first material, the vacuum source configured to apply a reduced pressure to skin to remove the released fluid from the subject; a shell made of a second material having a higher Young's modulus than the first material, the device actuator being movable relative to the shell; and Equipped with movement of the device actuator relative to the shell causes compression of the flexible dome; A device, wherein actuation of the device actuator activates the vacuum source and activates the one or more flow activators to pierce the skin of the subject such that fluid is received from the subject into the device when the skin of the subject is subjected to the reduced pressure by the vacuum source.

2. The device of claim 1, wherein the shell includes an opening, and at least a portion of the device actuator extends through the opening.

3. The device of claim 2, wherein the device actuator includes a user-contact portion and a stem, the stem extending through an opening in the shell.

4. A device as described in any one of claims 1 to 3, wherein the flexible dome has a first shape prior to compression and a second shape during compression, and the flexible dome is biased to return to its first shape when the flexible dome is no longer under compression.

5. The device of claim 4, wherein the return of the flexible dome from the second shape to the first shape creates a vacuum.

6. The device of claim 5, further comprising a one-way vent that allows air to move through the vent during compression of the flexible dome from the first shape to the second shape, but prevents air from moving through the vent during return of the flexible dome from the second shape to the first shape.

7. A device as described in any one of claims 1 to 6, wherein the flexible dome includes a wall having a recessed circumferential shoulder.

8. A device as described in any one of claims 1 to 7, further comprising a ratchet mechanism that resists movement of the device actuator relative to the shell in a direction away from the flexible dome.

9. The device of claim 8, wherein the ratchet mechanism comprises a ratchet and a pawl.

10. The device of claim 9, wherein the pawl is attached to the shell and the ratchet is attached to the device actuator.

11. The device described in claim 10, wherein the device actuator includes a user contact portion and a stem, and the ratchet is located on the stem.

12. A device as described in any one of claims 10 or 11, wherein the shell includes an opening, at least a portion of the device actuator extends through the opening, and the claw is located within the opening.

13. A device as described in any one of claims 9 to 12, wherein the ratchet includes a plurality of teeth and a first tooth, the user contact portion being further away from the first tooth than the plurality of teeth, and the first tooth being reversed in orientation relative to the plurality of teeth.

14. A device as described in any one of claims 1 to 13, further comprising a retraction actuator and a puncture assembly including a deployment actuator and the one or more flow activators, the puncture assembly being movable in a deployment direction toward the opening, and the retraction actuator being compressed during movement of the puncture assembly toward the opening.

15. The device described in claim 14, wherein the deployment actuator stores potential energy during movement of the puncture assembly toward the opening.

16. A device as described in any one of claims 14 or 15, wherein the deployment actuator releases stored potential energy in response to contact between the puncture assembly and the user's skin, causing the one or more flow activators to move toward the user's skin and puncture the user's skin.

17. A device as described in any one of claims 14 to 16, wherein the retraction actuator comprises a spring having one or more cantilevered spiral arms.

18. A device as described in any one of claims 14 to 17, wherein the puncture assembly further includes a guide housing, the one or more flow activators are movable through at least a portion of the guide housing during deployment, and the guide housing contacts the retraction spring.

19. The device of claim 18, wherein the retraction spring slides against the guide housing during compression of the retraction spring.

20. A device as described in any one of claims 14, 17, or 19, wherein the retraction actuator is attached to the support.

21. The device of claim 18, wherein the guide housing includes a notch that contacts the retraction spring.

22. A device as described in any one of claims 18 to 21, wherein the puncture assembly further includes a latch engaged with a support on the guide housing, the latch being movable through at least a portion of the guide housing when the latch is released.

23. The device of claim 22, further comprising a latch release, wherein movement of the latch release beyond a threshold travel distance disengages the latch from the support.

24. A device as described in any one of claims 22 or 23, further comprising a latch release, wherein an actuation force applied to the latch release that exceeds a threshold force disengages the latch from the support independent of the travel distance of the latch release.

25. A device described in any one of claims 22 to 24, wherein the guide housing includes a latch track that guides linear movement of the latch through the guide housing.

26. A device described in any one of claims 18 to 25, wherein the support includes a guide housing track that guides linear movement of the guide housing relative to the support.

27. ​​A device as described in any one of claims 14 to 26, wherein the deployment actuator comprises a deployment spring and the retraction actuator comprises a retraction spring, the spring constant of the deployment spring being stiffer than the spring constant of the retraction spring.

28. A device as described in any one of claims 14 to 27, wherein the deployment actuator comprises a deployment spring and the retraction actuator comprises a retraction spring, the deployment spring and the retraction spring being arranged in series.

29. A device as described in any one of claims 14 to 18, wherein the deployment actuator comprises a deployment spring and the retraction actuator comprises a retraction spring, the deployment spring and the retraction spring being arranged in parallel.

30. A device as described in any one of claims 22 to 29, wherein the puncture assembly further includes a push cap including a contact surface configured to contact the latch to release the latch, the deployment spring being compressed between the push cap and the latch as the push cap moves toward the latch, and actuation of the device moves the push cap in a deployment direction toward the opening.

31. The device described in claim 30, wherein the guide housing includes a push cap track that guides linear movement of the push cap through the guide housing.

32. A device as described in any one of claims 30 or 31, wherein the deployment spring is attached to the push cap.

33. A device as described in any one of claims 22 to 32, wherein the deployment actuator comprises a deployment spring, and the latch and the deployment spring are integrally formed as a single component.

34. A device as described in any one of claims 22 to 33, further comprising a latch release, the deployment actuator comprising a deployment spring, the latch release and the deployment spring being integrally formed as a single component.

35. A device as described in any one of claims 22 to 33, further comprising a latch release, the deployment actuator comprising a deployment spring, and the latch, latch release, and deployment spring being integrally formed as a single component.

36. The device of claim 14, wherein the deployment actuator comprises a spring having an undulating, non-coiled shape.

37. A device as described in any one of claims 18 to 22, wherein the guide housing includes a spring track that receives at least a portion of the spring and guides linear movement of the spring through the guide housing.

38. A device as described in any one of claims 22 to 37, wherein the latch has a latch width extending from a first arm of the latch to a second arm of the latch, and the deployment actuator comprises a spring having an undulating non-coiled shape, the spring having a spring width extending from a first curve of the spring to a second curve of the spring, the first and second curves point in opposing directions, and the spring width is oriented perpendicular to the latch width.

39. A device as described in any one of claims 1 to 38, further comprising a puncture assembly including a deployment actuator and the one or more flow activators, and further comprising a positive stop portion limiting the distance of travel of the one or more flow activators.

40. The device of claim 39, wherein the positive stop comprises a peg that abuts against a contact surface.

41. The device of claim 40, further comprising a guide housing, wherein the one or more flow activators are movable through at least a portion of the guide housing during deployment, the peg is coupled to the deployment actuator, and the contact surface is coupled to the guide housing.

42. The device of claim 6, wherein the one-way vent is provided with an umbrella valve.

43. A device as described in any one of claims 1 to 6, wherein the flexible dome is more difficult to compress during an initial phase of compression than during a final phase of compression.